Case number 1:22-cv-00294
Novo Nordisk Inc. et al v. Rio Biopharmaceuticals, Inc. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Dec 13, 2024 | 372 | SO ORDERED, re (422 in 1:22-md-03038-CFC-EGT, 36 in 1:22-cv-00297-CFC, 371 in 1:22-cv-00294-CFC-EGT) Stipulation of Dismissal Among Novo Nordisk Inc., Novo Nordisk A/S, Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc., and Zydus Lifesciences, filed by Novo Nordisk A/S, Novo Nordisk Inc. (Terminating Hearings: 12/16/2024 Bench Trial terminated.) Signed by Judge Colm F. Connolly on 12/13/2024. Associated Cases: 1:22-cv-00294-CFC-EGT, 1:22-cv-00297-CFC, 1:22-md-03038-CFC-EGT(kmd) (Entered: 12/13/2024) (3) |
| Dec 13, 2024 | 373 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,132,239 B2; 10,335,462 B2; 8,129,343 B2; 8,920,383 B2; 9,457,154 B2; 9,775,953 B2. (Attachments: # 1 Stipulation of Dismissal) (mws) (Entered: 12/13/2024) (0) |
| Dec 12, 2024 | 371 | STIPULATION of Dismissal Among Novo Nordisk Inc., Novo Nordisk A/S, Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc., and Zydus Lifesciences by Novo Nordisk Inc., Novo Nordisk A/S. (Egan, Brian) (Entered: 12/12/2024) (3) |
| Dec 6, 2024 | 369 | MOTION for Limited Exemption from the Standing Order Regarding Personal Electronic Devices - filed by Novo Nordisk Inc., Novo Nordisk A/S. Motions referred to Eleanor G. Tennyson.(Murray, Travis) (Entered: 12/06/2024) (3) |
| Dec 6, 2024 | 370 | SO ORDERED, re (369 in 1:22-cv-00294-CFC-EGT, 420 in 1:22-md-03038-CFC-EGT) MOTION for Limited Exemption from the Standing Order Regarding Personal Electronic Devices, filed by Novo Nordisk A/S, Novo Nordisk Inc. Signed by Judge Colm F. Connolly on 12/6/2024. Associated Cases: 1:22-md-03038-CFC-EGT, 1:22-cv-00294-CFC-EGT (kmd) (Entered: 12/06/2024) (3) |
| Dec 3, 2024 | 367 | STIPULATION of Dismissal (as to Defendants Rio Biopharmaceuticals, Inc. and EMS S/A - without prejudice) by Novo Nordisk Inc., Novo Nordisk A/S. (Murray, Travis) (Entered: 12/03/2024) (3) |
| Dec 3, 2024 | 368 | ORDER re (367 in 1:22-cv-00294-CFC-EGT, 418 in 1:22-md-03038-CFC-EGT) Stipulation of Dismissal (as to Defendants Rio Biopharmaceuticals, Inc. and EMS S/A - without prejudice). Party EMS S/A and Rio Biopharmaceuticals, Inc. terminated. Signed by Judge Colm F. Connolly on 12/3/2024. Associated Cases: 1:22-md-03038-CFC-EGT, 1:22-cv-00294-CFC-EGT(mws) (Entered: 12/03/2024) (3) |
| Nov 15, 2024 | 363 | ORDER granting (361 in case 1:22-cv-00294-CFC-EGT; 411 in case 1:22-md-03038-CFC-EGT) MOTION for Exemption from the Standing Order Regarding Personal Electronic Devices. Signed by Judge Colm F. Connolly on 11/14/2024. Associated Cases: 1:22-md-03038-CFC-EGT, 1:22-cv-00294-CFC-EGT (kmd) (Entered: 11/15/2024) (3) |
| Nov 15, 2024 | 364 | ORAL ORDER: Defendants' motion for exemption of persons from the Court's standing order regarding electronic devices (D.I. 362 in 22-294, D.I. 412 in 22-md-3038) is DENIED. The motion asks that the Court exempt certain persons from the standing order but does not identify who the certain persons are. The motion intimates that the universe of certain persons may consist of only four individuals (two of whom the Court believes are Delaware lawyers who one would think meet the exemptions listed in paragraph 4 of the standing order), but the Court cant be sure that is the case. Finally, the motion does not identify what role if any these four individuals play in the case or why these four individuals need their phones during the pretrial conference. Ordered by Judge Colm F. Connolly on 11/15/2024. Associated Cases: 1:22-md-03038-CFC-EGT, 1:22-cv-00294-CFC-EGT(mws) (Entered: 11/15/2024) (0) |
| Nov 15, 2024 | 365 | Amended MOTION For Exemption from May 17, 2024 Standing Order on Personal Devices - filed by Rio Biopharmaceuticals, Inc., EMS S/A. Motion no longer referred to Eleanor G. Tennyson.(Dorsney, Kenneth) (Entered: 11/15/2024) (3) |
| Nov 15, 2024 | 366 | ORDER granting (365 in case 1:22-cv-00294-CFC-EGT; 415 in case 1:22-md-03038-CFC-EGT) Amended MOTION For Exemption from May 17, 2024 Standing Order on Personal Devices. Signed by Judge Colm F. Connolly on 11/15/2024. Associated Cases: 1:22-cv-00294-CFC-EGT, 1:22-md-03038-CFC-EGT (kmd) (Entered: 11/15/2024) (3) |
| Nov 14, 2024 | 361 | MOTION for Exemption from the Standing Order Regarding Personal Electronic Devices - filed by Novo Nordisk Inc., Novo Nordisk A/S. Motions no longer referred to Eleanor G. Tennyson.(Murray, Travis) (Entered: 11/14/2024) (3) |
| Nov 14, 2024 | 362 | MOTION For Exemption from May 17, 2024 Standing Order on Personal Devices - filed by Rio Biopharmaceuticals, Inc., EMS S/A. Motions no longer referred to Eleanor G. Tennyson.(Dorsney, Kenneth) (Entered: 11/14/2024) (3) |
| Nov 8, 2024 | 360 | NOTICE OF SERVICE of Defendants' Joint Section 282 Notice filed by EMS S/A, Rio Biopharmaceuticals, Inc..(Dorsney, Kenneth) (Entered: 11/08/2024) (3) |
| Nov 5, 2024 | 359 | ORDER: having reviewed the joint status report filed by the parties on October 31, 2024 (D.1. 406) and the Proposed Pretrial Order (D.I. 405), it is HEREBY ORDERED that Defendants' decision to "not include[] any invalidity theories against the [#]343 patent in the Proposed Joint Pretrial Order," D.I. 406 at 2, constitutes a waiver of their right to challenge the validity of the #343 patent at the trial scheduled to begin on December 9, 2024. Signed by Judge Colm F. Connolly on 11/5/2024. Associated Cases: 1:22-md-03038-CFC-EGT, 1:22-cv-00294-CFC-EGT(mws) (Entered: 11/05/2024) (2) |
| Nov 4, 2024 | 358 | REDACTED VERSION of (355 in 1:22-cv-00294-CFC-EGT, 405 in 1:22-md-03038-CFC-EGT) Proposed Pretrial Order,,,, by Novo Nordisk A/S, Novo Nordisk Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 6A, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15)(Murray, Travis) (Entered: 11/04/2024) (0) |
| Nov 1, 2024 | 357 | REDACTED VERSION of (406 in 1:22-md-03038-CFC-EGT, 356 in 1:22-cv-00294-CFC-EGT) Status Report - by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 11/01/2024) (3) |
| Oct 31, 2024 | 356 | [SEALED] Joint STATUS REPORT - by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 10/31/2024) (0) |
| Oct 28, 2024 | 354 | SO ORDERED, re (403 in 1:22-md-03038-CFC-EGT, 353 in 1:22-cv-00294-CFC-EGT) Joint STIPULATION and [Proposed] Order Regarding Infringement of the '343 and '462 Patents, filed by Novo Nordisk A/S, Novo Nordisk Inc. Signed by Judge Colm F. Connolly on 10/28/2024. Associated Cases: 1:22-md-03038-CFC-EGT, 1:22-cv-00294-CFC-EGT (kmd) (Entered: 10/28/2024) (6) |
| Oct 28, 2024 | 355 | [SEALED] Proposed Pretrial Order (Joint) - by Novo Nordisk A/S, Novo Nordisk Inc.. (Attachments: # 1 Exhibit 1 - Statement of Uncontested Facts, # 2 Exhibit 2 - Plaintiffs' Statement of Issues of Fact, # 3 Exhibit 3 - Defendants' Statement of Issues of Fact, # 4 Exhibit 4 - Plaintiffs' Statement of Issues of Law, # 5 Exhibit 5 - Defendants' Statement of Issues of Law, # 6 Exhibit 6 - Plaintiffs' Witness List, # 7 Exhibit 6A - Plaintiffs' Expert Testimony, # 8 Exhibit 7 - Defendants' Witness List, # 9 Exhibit 8 - Deposition Designations, Counters, and Objs, # 10 Exhibit 9 - Joint Trial Exhibit List (JTX), # 11 Exhibit 10 - Plaintiffs' Trial Exhibit List (PTX), # 12 Exhibit 11 - Defendants' Trial Exhibit List (DTX), # 13 Exhibit 12 - Plaintiffs' Statement of Intended Proofs, # 14 Exhibit 13 - Defendants' Statement of Intended Proofs, # 15 Exhibit 14 - Plaintiffs' Motions in Limine (Nos. 2&3), # 16 Exhibit 15 - Plaintiffs' Statement of Additional Issues to be Resolved)(Murray, Travis) (Entered: 10/28/2024) (0) |
| Oct 25, 2024 | 353 | Joint STIPULATION and [Proposed] Order Regarding Infringement of the '343 and '462 Patents by Rio Biopharmaceuticals Inc. and EMS S/A by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 10/25/2024) (6) |
| Oct 16, 2024 | 350 | SO ORDERED, re (347 in 1:22-cv-00294-CFC-EGT, 397 in 1:22-md-03038-CFC-EGT, 25 in 1:22-cv-00296-CFC) Stipulation of Dismissal without prejudice as to Sun Pharmaceutical Industries Ltd. and Sun Pharmaceutical Industries, Inc., filed by Novo Nordisk A/S, Novo Nordisk Inc. Party Sun Pharmaceutical Industries Inc. and Sun Pharmaceutical Industries Ltd. terminated. Signed by Judge Colm F. Connolly on 10/16/2024. Associated Cases: 1:22-md-03038-CFC-EGT, 1:22-cv-00294-CFC-EGT, 1:22-cv-00296-CFC (kmd) (Entered: 10/16/2024) (3) |
| Oct 16, 2024 | 351 | SO ORDERED, re (348 in 1:22-cv-00294-CFC-EGT, 398 in 1:22-md-03038-CFC-EGT, 26 in 1:22-cv-00298-CFC) Stipulation of Dismissal filed by Novo Nordisk A/S, Novo Nordisk Inc. Party Dr. Reddy's Laboratories Inc. and Dr. Reddy's Laboratories Ltd. terminated. Signed by Judge Colm F. Connolly on 10/16/2024. Associated Cases: 1:22-md-03038-CFC-EGT, 1:22-cv-00294-CFC-EGT, 1:22-cv-00298-CFC(mws) (Entered: 10/16/2024) (3) |
| Oct 16, 2024 | 352 | SO ORDERED, re (399 in 1:22-md-03038, 349 in 1:22-cv-00294-CFC-EGT) STIPULATION and [Proposed] Order to Extend Close of Expert Discovery and Daubert Motion Deadlines; Reset Scheduling Order Deadlines: ( Expert Discovery due by 10/16/2024). Signed by Judge Colm F. Connolly on 10/16/2024. Associated Cases: 1:22-md-03038-CFC-EGT, 1:22-cv-00294-CFC-EGT (mws) (Entered: 10/17/2024) (4) |
| Oct 9, 2024 | 349 | STIPULATION and [Proposed] Order to Extend Close of Expert Discovery and Daubert Motion Deadlines - by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 10/09/2024) (4) |
| Oct 8, 2024 | 347 | STIPULATION of Dismissal without prejudice as to Sun Pharmaceutical Industries Ltd. and Sun Pharmaceutical Industries, Inc. (C.A. No. 22-296) - by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 10/08/2024) (3) |
| Oct 8, 2024 | 348 | STIPULATION of Dismissal without prejudice as to Dr. Reddy's Laboratories, Ltd. and Dr. Reddy's Laboratories, Inc. (C.A. No. 22-298) - by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 10/08/2024) (3) |
| Oct 2, 2024 | 346 | NOTICE to Take Deposition of Mikhail Kosiborod (Amended) filed by EMS S/A, Rio Biopharmaceuticals, Inc..(Dorsney, Kenneth) (Entered: 10/02/2024) (4) |
| Sep 25, 2024 | 344 | Joint STIPULATION and [Proposed] Order Regarding the '343 Patent - by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 09/25/2024) (5) |
| Sep 25, 2024 | 345 | SO ORDERED, re (392 in 1:22-md-03038-CFC-EGT, 344 in 1:22-cv-00294-CFC-EGT) Joint STIPULATION and Order Regarding the '343 Patent. Signed by Judge Colm F. Connolly on 9/25/2024. Associated Cases: 1:22-md-03038-CFC-EGT, 1:22-cv-00294-CFC-EGT(mws) (Entered: 09/25/2024) (5) |
| Sep 19, 2024 | 343 | NOTICE requesting Clerk to remove Silvia M. Medina as co-counsel. Reason for request: no longer with the firm. (Murray, Travis) (Entered: 09/19/2024) (7) |
| Sep 18, 2024 | 341 | Official Transcript of Telephone Conference held on September 12, 2024 before Chief Judge Connolly. Court Reporter/Transcriber Bonnie Archer, Email: Bonnie_Archer@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 10/9/2024. Redacted Transcript Deadline set for 10/21/2024. Release of Transcript Restriction set for 12/17/2024. (nmf) (Entered: 09/18/2024) (11) |
| Sep 18, 2024 | 342 | REDACTED VERSION of (257 in 1:22-cv-01040-CFC-EGT, 340 in 1:22-cv-00294-CFC-EGT) Letter by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 09/18/2024) (1) |
| Sep 11, 2024 | 338 | STIPULATION and [Proposed] Order to Extend Close of Expert Discovery and Daubert Motion Deadlines - by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 09/11/2024) (5) |
| Sep 11, 2024 | 339 | SO ORDERED, re (388 in 1:22-md-03038-CFC-EGT, 338 in 1:22-cv-00294-CFC-EGT, 255 in 1:22-cv-01040-CFC-EGT) Stipulation to Extend Close of Expert Discovery and Daubert Motion Deadlines, filed by Novo Nordisk A/S, Novo Nordisk Inc. Reset Scheduling Order Deadlines: Expert Discovery due by 10/9/2024. Signed by Judge Colm F. Connolly on 9/11/2024. Associated Cases: 1:22-cv-00294-CFC-EGT, 1:22-cv-01040-CFC-EGT, 1:22-md-03038-CFC-EGT (kmd) (Entered: 09/11/2024) (5) |
| Sep 11, 2024 | 340 | [SEALED] Joint Letter to The Honorable Colm F. Connolly from Stamatios Stamoulis and Travis J. Murray regarding Case Status. (Stamoulis, Stamatios) (Entered: 09/11/2024) (0) |
| Sep 10, 2024 | 337 | NOTICE of Appearance by Sara M. Metzler on behalf of Sun Pharmaceutical Industries Ltd., Sun Pharmaceuticals Industries Inc., Sun Pharmaceutical Industries Inc. (Metzler, Sara) (Entered: 09/10/2024) (2) |
| Sep 9, 2024 | 336 | Letter to The Honorable Colm F. Connolly from Travis J. Murray regarding the date of the pretrial conference. (Murray, Travis) (Entered: 09/09/2024) (2) |
| Aug 30, 2024 | 335 | NOTICE to Take Deposition of Christopher A. Vellturo on September 5, 2024 filed by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC.(Stombaugh, Alexis) (Entered: 08/30/2024) (6) |
| Aug 21, 2024 | 334 | NOTICE to Take Deposition of George Grunberger on August 28, 2024 filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 08/21/2024) (7) |
| Aug 20, 2024 | 332 | SO ORDERED, re (251 in 1:22-cv-01040-CFC-EGT, 381 in 1:22-md-03038-CFC-EGT, 331 in 1:22-cv-00294-CFC-EGT) STIPULATION TO EXTEND TIME for Close of Expert Discovery and Daubert Motion Deadlines to Various Dates, filed by Novo Nordisk A/S, Novo Nordisk Inc. Signed by Judge Colm F. Connolly on 8/20/2024. Associated Cases: 1:22-md-03038-CFC-EGT, 1:22-cv-00294-CFC-EGT, 1:22-cv-01040-CFC-EGT (kmd) (Entered: 08/20/2024) (7) |
| Aug 20, 2024 | 333 | NOTICE to Take Deposition of John B. Buse, M.D., PH.D. on August 30, 2024 at 9:00 am filed by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Ltd..(Gattuso, Dominick) (Entered: 08/20/2024) (5) |
| Aug 19, 2024 | 331 | STIPULATION TO EXTEND TIME for Close of Expert Discovery and Daubert Motion Deadlines to Various Dates - filed by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 08/19/2024) (7) |
| Aug 16, 2024 | 323 | NOTICE to Take Deposition of Virginia W. Cornish, Ph.D. on August 27, 2024 filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 08/16/2024) (7) |
| Aug 16, 2024 | 324 | NOTICE to Take Deposition of William J. Jusko, Ph.D. on August 30, 2024 filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 08/16/2024) (7) |
| Aug 16, 2024 | 325 | NOTICE to Take Deposition of Arthur Z. Schwartzbard, M.D., F.A.C.C. on August 30, 2024 filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 08/16/2024) (7) |
| Aug 16, 2024 | 326 | NOTICE to Take Deposition of Paul Dalby, Ph.D. on September 10, 2024 filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 08/16/2024) (7) |
| Aug 16, 2024 | 327 | NOTICE to Take Deposition of John P. Bantle, M.D. on September 12, 2024 filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 08/16/2024) (7) |
| Aug 16, 2024 | 328 | NOTICE to Take Deposition of Patrick J. Sinko, Ph.D. on August 21, 2024 filed by Mylan Pharmaceuticals Inc..(Stamoulis, Stamatios) (Entered: 08/16/2024) (6) |
| Aug 16, 2024 | 329 | NOTICE to Take Deposition of Michael E. Trautmann, M.D. on September 5, 2024 filed by Mylan Pharmaceuticals Inc..(Stamoulis, Stamatios) (Entered: 08/16/2024) (6) |
| Aug 16, 2024 | 330 | NOTICE to Take Deposition of Mikhail Kosiborod, M.D. on September 5, 2024 filed by Mylan Pharmaceuticals Inc..(Stamoulis, Stamatios) (Entered: 08/16/2024) (6) |
| Aug 11, 2024 | 322 | NOTICE to Take Deposition of Christopher A. Vellturo, Ph.D. on August 13, 2024 filed by Mylan Pharmaceuticals Inc..(Stamoulis, Stamatios) (Entered: 08/11/2024) (6) |
| Aug 8, 2024 | 321 | STIPULATION Regarding Invalidity Grounds for U.S. Patent No. 10,335,462 by Mylan Pharmaceuticals Inc.. (Stamoulis, Stamatios) (Entered: 08/08/2024) (9) |
| Aug 6, 2024 | 318 | NOTICE to Take Deposition of Thomas W. Muir, Ph.D. on August 9, 2024 filed by Sun Pharmaceutical Industries Ltd., Sun Pharmaceuticals Industries Inc., Sun Pharmaceutical Industries Inc..(Metzler, Sara) (Entered: 08/06/2024) (5) |
| Aug 6, 2024 | 319 | NOTICE to Take Deposition of Randall Zusman, M.D. on August 13, 2024 filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 08/06/2024) (7) |
| Aug 6, 2024 | 320 | NOTICE to Take Deposition of Herbert Lin, M.D., Ph.D. on August 16, 2024 filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 08/06/2024) (7) |
| Aug 5, 2024 | 316 | NOTICE to Take Deposition of Lee M. Kaplan, MD,PhD on August 14, 2024 filed by Mylan Pharmaceuticals Inc..(Stamoulis, Stamatios) (Entered: 08/05/2024) (6) |
| Aug 5, 2024 | 317 | NOTICE to Take Deposition of Matthew R. Weir, M.D. on August 8, 2024 filed by Mylan Pharmaceuticals Inc..(Stamoulis, Stamatios) (Entered: 08/05/2024) (6) |
| Aug 1, 2024 | 315 | NOTICE of Order Issued in Parallel Inter Partes Review by Novo Nordisk A/S, Novo Nordisk Inc. (Attachments: # 1 Exhibit A, # 2 Exhibit B)(Murray, Travis) (Entered: 08/01/2024) (0) |
| Jul 30, 2024 | 313 | NOTICE to Take Deposition of Dr. Allen Spiegel on July 31, 2024 filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 07/30/2024) (7) |
| Jul 30, 2024 | 314 | NOTICE to Take Deposition of DeForest McDuff, Ph.D. on August 1, 2024 filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 07/30/2024) (7) |
| Jul 18, 2024 | 311 | MOTION for Pro Hac Vice Appearance of Attorney Aaron M. Johnson - filed by EMS S/A, Rio Biopharmaceuticals, Inc.. (Hitch, Cortlan) (Entered: 07/18/2024) (2) |
| Jul 18, 2024 | 312 | Pro Hac Vice Fee - Credit Card Payment received for Aaron M. Johnson. ( re 311 MOTION for Pro Hac Vice Appearance of Attorney Aaron M. Johnson )( Payment of $ 50, receipt number ADEDC-4454056).(Hitch, Cortlan) (Entered: 07/18/2024) (0) |
| Jul 17, 2024 | 307 | Letter to The Honorable Eleanor G. Tennyson from Travis J. Murray regarding Discovery Dispute - re (224 in 1:22-cv-01040-CFC-EGT, 352 in 1:22-md-03038-CFC-EGT) Letter,. (Attachments: # 1 Ex. C, # 2 Ex. D)(Murray, Travis) (Entered: 07/17/2024) (0) |
| Jul 17, 2024 | 308 | NOTICE OF SERVICE of (1) Defendants' Joint Reply expert Report of Dr. Paul Dalby; (2) Defendants' Joint Reply Expert Report of William J. Jusko, Ph.D. regarding Invalidity of U.S. Patent No. 10,335,492 and; (3) Defendants' Joint Reply Expert Report of Dr. John Bantle regarding Invalidity of U.S. No. 10,335,462 filed by EMS S/A, Rio Biopharmaceuticals, Inc..(Hitch, Cortlan) (Entered: 07/17/2024) (3) |
| Jul 17, 2024 | 309 | NOTICE OF SERVICE of (1) Reply Expert Report of Plaintiffs' Expert John B. Buse, M.D., Ph.D. Regarding Objective Indicia; (2) Reply Expert Report of Plaintiffs' Expert Lee M. Kaplan, M.D., Ph.D.; (3) Reply Expert Report of Plaintiffs' Expert Mikhail N. Kosiborod, M.D.; (4) Reply Expert Report of Plaintiffs' Expert Thomas W. Muir, Ph.D.; (5) Reply Expert Report of Christopher A. Vellturo, Ph.D.; (6) Reply Expert Report of Plaintiffs' Expert Matthew R. Weir, M.D.; (7) Reply Expert Report of Plaintiffs' Expert John B. Buse, M.D., Ph.D. Regarding Infringement of U.S. Patent No. 10,335,462 by Dr. Reddy's Laboratories Ltd. & Dr. Reddy's Laboratories, Inc., Sun Pharmaceutical Industries Ltd. & Sun Pharmaceutical Industries, Inc., and Mylan Pharmaceuticals Inc.; and (8) Reply Expert Report of Plaintiffs' Expert Patrick Sinko, Ph.D. Regarding Infringement of U.S. Patent No. 10,335,462 by Dr. Reddy's Laboratories Ltd. & Dr. Reddy's Laboratories, Inc., Sun Pharmaceutical Industries Ltd. & Sun Pharmaceutical Industries, Inc. and Mylan Pharmaceuticals Inc. - filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 07/17/2024) (14) |
| Jul 17, 2024 | 310 | NOTICE OF SERVICE of the Reply Expert Report of Virginia W. Cornish, Ph.D. on Validity of U.S. Patent No. 8,129,343 filed by Sun Pharmaceutical Industries Ltd., Sun Pharmaceuticals Industries Inc..(Metzler, Sara) (Entered: 07/17/2024) (3) |
| Jul 12, 2024 | 304 | ORAL ORDER - In light of the recent referral of discovery disputes to the undersigned, IT IS HEREBY ORDERED that the briefing for the July 19, 2024 discovery conference shall proceed consistent with the Scheduling Order entered in this case. IT IS FURTHER ORDERED that the July 19, 2024 hearing is converted to a teleconference. Counsel shall provide a dial-in number for the teleconference by emailing egt_civil@ded.uscourts.gov. ORDERED by Judge Eleanor G. Tennyson on 7/12/2024. Associated Cases: 1:22-md-03038-CFC, 1:22-cv-00294-CFC, 1:22-cv-01040-CFC. (Entered: 07/12/2024) (0) |
| Jul 12, 2024 | 305 | Joint STIPULATION TO EXTEND TIME Reply Expert Reports to July 16, 2024 and Close of Expert Discovery August 19, 2024 - filed by Mylan Pharmaceuticals Inc. (Stamoulis, Stamatios) Modified on 7/16/2024 (nmf). (Entered: 07/12/2024) (6) |
| Jul 12, 2024 | 306 | SO ORDERED, re (349 in 1:22-md-03038-CFC, 221 in 1:22-cv-01040-CFC, 305 in 1:22-cv-00294-CFC) Joint STIPULATION TO EXTEND TIME Reply Expert Reports to July 16, 2024 and Close of Expert Discovery August 19, 2024. ORDER Resetting Scheduling Order Deadlines: Rebuttal Expert Reports due by 7/16/2024. Expert Discovery due by 8/19/2024. Signed by Judge Colm F. Connolly on 7/12/2024. Associated Cases: 1:22-md-03038-CFC, 1:22-cv-00294-CFC, 1:22-cv-01040-CFC (kmd) Modified on 7/16/2024 (nmf). (Entered: 07/12/2024) (6) |
| Jun 17, 2024 | 303 | NOTICE OF SERVICE of (1) Rebuttal Expert Report of Plaintiffs' Expert Thomas W. Muir, Ph.D. and (2) Rebuttal Expert Report of Plaintiffs' Expert Michael E. Trautmann, M.D. Regarding U.S. Patent No. 8,129,343 - filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 06/17/2024) (10) |
| Jun 3, 2024 | 300 | NOTICE OF SERVICE of (i) Responsive Expert Report of Randall Zusman, M.D. [CONFIDENTIAL]; and, (ii) the accompanying production bates labeled SEMA(DMS)_0000001-SEMA(DMS)_0000055 filed by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Ltd..(Gattuso, Dominick) (Entered: 06/03/2024) (3) |
| Jun 3, 2024 | 301 | NOTICE OF SERVICE of (1) Rebuttal Expert Report of Michael E. Trautmann, M.D. Regarding Validity of U.S. Patent No. 10,335,462 and (2) Rebuttal Expert Report of Patrick Sinko, Ph.D. Regarding Validity of U.S. Patent No. 10,335,462 - filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 06/03/2024) (10) |
| Jun 3, 2024 | 302 | NOTICE OF SERVICE of (1) Rebuttal Expert Report of Dr. Herbert Lin Regarding U.S. Patent Nos. 8,129,343 and 10,335,462, (2) Rebuttal Expert Report of Virginia W. Cornish, Ph.D., on Objective Indicia of U.S. Patent 8,129,343, (3) Responsive Expert Report of Arthur Z. Schwartzbard, M.D., F.A.C.C., (4) Rebuttal Expert Report of Dr. Allen Spiegel Regarding Invalidity of U.S. Patent No. 10,335,462, (5) Rebuttal Expert Report of Dr. George Grunberger Regarding Invalidity of U.S. Patent No. 10,335,462, and (6) Expert Report of DeForest McDuff, Ph.D. filed by Mylan Pharmaceuticals Inc..(Stamoulis, Stamatios) (Entered: 06/03/2024) (3) |
| May 31, 2024 | 298 | Joint STIPULATION and [Proposed] Order Amending Certain Expert Discovery Deadlines by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 05/31/2024) (5) |
| May 31, 2024 | 299 | SO ORDERED, re (298 in 1:22-cv-00294-CFC, 214 in 1:22-cv-01040-CFC, 342 in 1:22-md-03038-CFC) Stipulation Amending Certain Expert Discovery Deadlines, filed by Novo Nordisk A/S, Novo Nordisk Inc. Signed by Judge Colm F. Connolly on 5/31/2024. Associated Cases: 1:22-md-03038-CFC, 1:22-cv-00294-CFC, 1:22-cv-01040-CFC(kmd) (Entered: 05/31/2024) (5) |
| May 17, 2024 | 297 | NOTICE OF SERVICE of Opening Expert Report of Virginia W. Cornish, Ph.D. Regarding Invalidity of U.S. Patent 8,129,343 filed by Sun Pharmaceutical Industries Ltd., Sun Pharmaceuticals Industries Inc., Sun Pharmaceutical Industries Inc..(Farnan, Kelly) (Entered: 05/17/2024) (3) |
| May 14, 2024 | 293 | STIPULATION and [Proposed] Order Amending Certain Case Deadlines - by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 05/14/2024) (6) |
| May 14, 2024 | 294 | MOTION for Pro Hac Vice Appearance of Attorney Kyu Yun Kim of FENWICK & WEST LLP - filed by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 05/14/2024) (7) |
| May 14, 2024 | 295 | Pro Hac Vice Fee - Credit Card Payment received for Kyu Yun Kim of FENWICK & WEST LLP. ( re 294 MOTION for Pro Hac Vice Appearance of Attorney Kyu Yun Kim of FENWICK & WEST LLP )( Payment of $ 50, receipt number ADEDC-4406758).(Murray, Travis) (Entered: 05/14/2024) (0) |
| May 14, 2024 | 296 | SO ORDERED, re (335 in 1:22-md-03038-CFC, 207 in 1:22-cv-01040-CFC, 293 in 1:22-cv-00294-CFC) STIPULATION and Order Amending Certain Case Deadlines. ORDER Resetting Scheduling Order Deadlines: ( A Final Pretrial Conference is set for 10/29/2024 at 10:00 AM in Courtroom 4B before Judge Colm F. Connolly., Expert Discovery due by 8/16/2024., Proposed Pretrial Order due by 10/8/2024.) SEE ORDER FOR FURTHER DETAILS. Signed by Judge Colm F. Connolly on 5/14/2024. Associated Cases: 1:22-md-03038-CFC, 1:22-cv-00294-CFC, 1:22-cv-01040-CFC(nmf) (Entered: 05/14/2024) (6) |
| May 3, 2024 | 292 | STIPULATION Concerning Invalidity Grounds by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Ltd.. (Gattuso, Dominick) (Entered: 05/03/2024) (3) |
| May 1, 2024 | 291 | STIPULATION of Invalidity Contentions by Sun Pharmaceutical Industries Ltd., Sun Pharmaceuticals Industries Inc.. (Metzler, Sara) (Entered: 05/01/2024) (3) |
| Apr 29, 2024 | 290 | SO ORDERED, re (205 in 1:22-cv-01040-CFC) STIPULATION TO EXTEND TIME to serve rebuttal expert reports to May 24, 2024 filed by Novo Nordisk A/S, Novo Nordisk Inc., (289 in 1:22-cv-00294-CFC, 331 in 1:22-md-03038-CFC) STIPULATION TO EXTEND TIME to serve rebuttal expert reports to May 24, 2024 filed by Novo Nordisk A/S, Novo Nordisk Inc. Signed by Judge Colm F. Connolly on 4/29/2024. Associated Cases: 1:22-md-03038-CFC, 1:22-cv-00294-CFC, 1:22-cv-01040-CFC(nmf) (Entered: 04/29/2024) (6) |
| Apr 26, 2024 | 289 | STIPULATION TO EXTEND TIME to serve rebuttal expert reports to May 24, 2024 - filed by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 04/26/2024) (6) |
| Mar 20, 2024 | 286 | NOTICE OF SERVICE of the Opening Expert Report of Zhaohui Sunny Zhou, Ph.D. Regarding Invalidity of U.S. Patent 8,129,343 filed by Sun Pharmaceutical Industries Ltd., Sun Pharmaceuticals Industries Inc., Sun Pharmaceutical Industries Inc..(Metzler, Sara) (Entered: 03/20/2024) (3) |
| Mar 20, 2024 | 287 | NOTICE OF SERVICE of (1) Opening Expert Report of Plaintiffs' Expert John B. Buse, M.D., Ph.D. Regarding Objective Indicia, (2) Opening Expert Report of Plaintiffs' Expert Thomas W. Muir, Ph.D., (3) Opening Expert Report of Plaintiffs' Expert Mikhail N. Kosiborod, M.D., (4) Opening Expert Report of Plaintiffs' Expert Lee M. Kaplan, M.D., Ph.D., (5) Opening Expert Report of Plaintiffs' Expert Matthew R. Weir, M.D., (6) Opening Expert Report of Christopher A. Vellturo, Ph.D., (7) Opening Expert Report of Plaintiffs' Expert John B. Buse, M.D., Ph.D. Regarding Infringement of U.S. Patent No. 10,335,462 by Mylan Pharmaceuticals Inc., (8) Opening Expert Report of Plaintiffs' Expert Patrick J. Sinko, Ph.D. Regarding Infringement by Defendants Mylan Pharmaceuticals Inc., (9) Opening Expert Report of Plaintiffs' Expert John B. Buse, M.D., Ph.D. Regarding Infringement of U.S. Patent No. 10,335,462 by Sun Pharmaceutical Industries Ltd. and Sun Pharmaceuticals Industries Inc., (10) Opening Expert Report of Plaintiffs' Expert William R. Roush, Ph.D. Regarding Infringement by Defendants Sun Pharmaceutical Industries Ltd. and Sun Pharmaceuticals Industries, Inc., (11) Opening Expert Report of Plaintiffs' Expert Patrick J. Sinko, Ph.D. Regarding Infringement by Defendants Sun Pharmaceutical Industries Ltd. and Sun Pharmaceuticals Industries, Inc., (12) Opening Expert Report of Plaintiffs' Expert John B. Buse, M.D., Ph.D. Regarding Infringement of U.S. Patent No. 10,335,462 by Rio Biopharmaceuticals Inc. and EMS S/A, (13) Opening Expert Report of Plaintiffs' Expert William R. Roush, Ph.D. Regarding Infringement by Defendants Rio Pharmaceuticals Incorporated and EMS S/A, (14) Opening Expert Report of Plaintiffs' Expert Patrick J. Sinko, Ph.D. Regarding Infringement by Defendants Rio Biopharmaceuticals Inc. and EMS S/A, (15) Opening Expert Report of Plaintiffs' Expert John B. Buse, M.D., Ph.D. Regarding Infringement of U.S. Patent No. 10,335,462 by Dr. Reddy's Laboratories Ltd. and Dr. Reddy's Laboratories, Inc., (16) Opening Expert Report of Plaintiffs' Expert Patrick J. Sinko, Ph.D. Regarding Infringement by Defendants Dr. Reddy's Laboratories Ltd. and Dr. Reddy's Laboratories, Inc. - filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 03/20/2024) (15) |
| Mar 20, 2024 | 288 | NOTICE OF SERVICE of (1) Opening Expert Report of William J. Jusko, Ph.D. Regarding Invalidity of U.S. Patent No. 10,335,462, (2) Opening Expert Report of Dr. John Bantle Regarding Invalidity of U.S. Patent No. 10,335,462, and (3) Opening Expert Report of Dr. Paul Dalby Regarding Invalidity of U.S. Patent No. 10,335,462 filed by Mylan Pharmaceuticals Inc..(Stamoulis, Stamatios) (Entered: 03/20/2024) (2) |
| Mar 18, 2024 | 284 | REDACTED VERSION of (280 in 1:22-cv-00294-CFC, 322 in 1:22-md-03038-CFC) Stipulation, by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Ltd.. (Gattuso, Dominick) (Entered: 03/18/2024) (5) |
| Mar 18, 2024 | 285 | REDACTED VERSION of (323 in 1:22-md-03038-CFC, 281 in 1:22-cv-00294-CFC) SO ORDERED, by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Ltd.. (Gattuso, Dominick) (Entered: 03/18/2024) (5) |
| Mar 15, 2024 | 283 | SO ORDERED, re (200 in 1:22-cv-01040-CFC, 324 in 1:22-md-03038-CFC, 282 in 1:22-cv-00294-CFC) STIPULATION TO EXTEND TIME Certain Deadlines Related to Experts to See Stipulation, filed by Mylan Pharmaceuticals Inc. Reset Scheduling Order Deadlines: Opening Expert Reports due by 3/19/2024. Rebuttal Expert Reports due by 4/26/2024. Expert Discovery due by 7/3/2024. Signed by Judge Colm F. Connolly on 3/15/2024. Associated Cases: 1:22-cv-00294-CFC, 1:22-cv-01040-CFC, 1:22-md-03038-CFC (kmd) (Entered: 03/15/2024) (5) |
| Mar 14, 2024 | 282 | STIPULATION TO EXTEND TIME Certain Deadlines Related to Experts to See Stipulation - filed by Mylan Pharmaceuticals Inc.. (Stamoulis, Stamatios) (Entered: 03/14/2024) (5) |
| Mar 13, 2024 | 281 | [SEALED] SO ORDERED, re (280 in 1:22-cv-00294-CFC, 322 in 1:22-md-03038-CFC) Stipulation Regarding Infringement of the '343 Patent by DRL Defendants and Dismissal as to DRL Defendants Regarding the '383 and '953 Patents, filed by Novo Nordisk A/S, Novo Nordisk Inc. Signed by Judge Colm F. Connolly on 3/13/2024. This order has been emailed to local counsel. Associated Cases: 1:22-md-03038-CFC, 1:22-cv-00294-CFC (kmd) (Entered: 03/13/2024) (0) |
| Mar 12, 2024 | 280 | [SEALED] STIPULATION and [Proposed] Order Regarding Infringement of the '343 Patent by DRL Defendants and Dismissal as to DRL Defendants Regarding the '383 and '953 Patents by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 03/12/2024) (0) |
| Mar 6, 2024 | 279 | NOTICE OF SERVICE of Plaintiffs' Responses to Defendant's Third Supplemental Invalidity Contentions Regarding U.S. Patent Nos. 8,920,383 and 9,775,953 - filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 03/06/2024) (7) |
| Mar 5, 2024 | 278 | NOTICE OF SERVICE of DRL's Supplemental Noninfringement Contentions for U.S. Patent Nos. 8,920,383 and 9,775,953 [CONFIDENTIAL] filed by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Ltd..(Gattuso, Dominick) (Entered: 03/05/2024) (2) |
| Feb 29, 2024 | 276 | STIPULATION TO EXTEND TIME to Supplement Noninfringement Contentions and Responses to Invalidity Contentions for the '953 and '383 patents to March 5, 2024 - filed by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 02/29/2024) (3) |
| Feb 29, 2024 | 277 | SO ORDERED, re (315 in 1:22-md-03038-CFC, 276 in 1:22-cv-00294-CFC, 194 in 1:22-cv-01040-CFC) STIPULATION TO EXTEND TIME to Supplement Noninfringement Contentions and Responses to Invalidity Contentions for the '953 and '383 patents to March 5, 2024, filed by Novo Nordisk A/S, Novo Nordisk Inc. Signed by Judge Colm F. Connolly on 2/29/2024. Associated Cases: 1:22-cv-00294-CFC, 1:22-cv-01040-CFC, 1:22-md-03038-CFC (kmd) (Entered: 02/29/2024) (3) |
| Feb 26, 2024 | 275 | STIPULATION of Invalidity Contentions by Sun Pharmaceutical Industries Ltd., Sun Pharmaceuticals Industries Inc., Sun Pharmaceutical Industries Inc.. (Metzler, Sara) (Entered: 02/26/2024) (3) |
| Feb 21, 2024 | 274 | SO ORDERED, re (192 in 1:22-cv-01040-CFC, 312 in 1:22-md-03038-CFC, 273 in 1:22-cv-00294-CFC) STIPULATION TO EXTEND TIME for the Deadline to Supplement Noninfringement Contentions and Responses to Invalidity Contentions for the 953 and 383 patents to February 29, 2024, filed by Mylan Pharmaceuticals Inc. Signed by Judge Colm F. Connolly on 2/21/2024. Associated Cases: 1:22-cv-01040-CFC, 1:22-cv-00294-CFC, 1:22-md-03038-CFC(kmd) (Entered: 02/21/2024) (3) |
| Feb 20, 2024 | 273 | STIPULATION TO EXTEND TIME for the Deadline to Supplement Noninfringement Contentions and Responses to Invalidity Contentions for the 953 and 383 patents to February 29, 2024 - filed by Mylan Pharmaceuticals Inc.. (Stamoulis, Stamatios) (Entered: 02/20/2024) (3) |
| Feb 12, 2024 | 272 | NOTICE OF SERVICE of Novo Nordisk's Responses to Defendants' Second Supplemental Invalidity Contentions Regarding U.S. Patent Nos. 8,129,343; 8,536,122; and 10,335,462 - filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 02/12/2024) (11) |
| Feb 9, 2024 | 269 | NOTICE OF SERVICE of DRL's First Amended Noninfringement Contentions regarding the 343 Patent and Second Amended Noninfringement Contentions regarding the 462 Patent [CONFIDENTIAL] filed by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Ltd..(Gattuso, Dominick) (Entered: 02/09/2024) (2) |
| Feb 9, 2024 | 270 | NOTICE OF SERVICE of Suns Final Non-Infringement Contentions filed by Sun Pharmaceutical Industries Inc., Sun Pharmaceutical Industries Ltd..(Metzler, Sara) (Entered: 02/09/2024) (2) |
| Feb 9, 2024 | 271 | STIPULATION TO EXTEND TIME of Certain Deadlines Related to Experts to See Stipulation - filed by Mylan Pharmaceuticals Inc.. (Stamoulis, Stamatios) (Entered: 02/09/2024) (3) |
| Feb 8, 2024 | 268 | REDACTED VERSION of (266 in 1:22-cv-00294-CFC, 304 in 1:22-md-03038-CFC) Stipulation - by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 02/08/2024) (4) |
| Feb 6, 2024 | 267 | [SEALED] SO ORDERED, re (266 in 1:22-cv-00294-CFC, 304 in 1:22-md-03038-CFC) Stipulation of Dismissal as to Sun Regarding the '383 and '953 Patents, filed by Novo Nordisk A/S, Novo Nordisk Inc.. Signed by Judge Colm F. Connolly on 2/6/2024. This order has been emailed to local counsel. Associated Cases: 1:22-md-03038-CFC, 1:22-cv-00294-CFC (kmd) (Entered: 02/06/2024) (0) |
| Feb 5, 2024 | 266 | [SEALED] STIPULATION and [Proposed] Order of Dismissal as to Sun Regarding the '383 and '953 Patents - by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 02/05/2024) (0) |
| Feb 1, 2024 | 264 | NOTICE OF SERVICE of Defendants' Third Supplemental Invalidity Contentions (with Exhibits D and E) [CONFIDENTIAL] filed by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Ltd..(Gattuso, Dominick) (Entered: 02/01/2024) (2) |
| Feb 1, 2024 | 265 | NOTICE OF SERVICE of Plaintiffs' Amended Infringement Contentions as to Dr. Reddy's Laboratories, Ltd. and Dr. Reddy's Laboratories, Inc. Regarding the '383 and '953 Patents - filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 02/01/2024) (5) |
| Jan 31, 2024 | 263 | SO ORDERED, re (298 in 1:22-md-03038-CFC, 262 in 1:22-cv-00294-CFC) STIPULATION TO EXTEND TIME for Novo Nordisk to serve on Sun supplemental infringement contentions and for Sun to serve on Novo Nordisk supplemental invalidity contentions as to the '383 patent and the '953 patent to February 8, 2024, filed by Novo Nordisk A/S, Novo Nordisk Inc. Signed by Judge Colm F. Connolly on 1/31/2024. Associated Cases: 1:22-cv-00294-CFC, 1:22-md-03038-CFC(kmd) (Entered: 01/31/2024) (3) |
| Jan 30, 2024 | 262 | STIPULATION TO EXTEND TIME for Novo Nordisk to serve on Sun supplemental infringement contentions and for Sun to serve on Novo Nordisk supplemental invalidity contentions as to the '383 patent and the '953 patent to February 8, 2024 - filed by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 01/30/2024) (3) |
| Jan 19, 2024 | 261 | NOTICE OF SERVICE of (1) Plaintiffs' Final Election of Asserted Claims for U.S. Patent No. 8,950,383 and U.S. Patent No. 9,775,953 to Defendants Dr. Reddy's Laboratories, Inc., and Dr. Reddy's Laboratories, Ltd. and (2) Plaintiffs' Final Election of Asserted Claims for U.S. Patent No. 8,950,383 and U.S. Patent No. 9,775,953 to Defendants Sun Pharmaceutical Industries Ltd. and Sun Pharmaceutical Industries, Inc. - filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 01/19/2024) (8) |
| Jan 16, 2024 | 259 | NOTICE OF SERVICE of (1) Plaintiffs' Amended Infringement Contentions as to Rio Biopharmaceuticals Inc. and EMS S/A Regarding the '343 and '462 Patents, (2) Plaintiffs' Amended Infringement Contentions as to Sun Pharmaceutical Industries Ltd. and Sun Pharmaceutical Industries Inc. Regarding the '343 and '462 Patents, and (3) Plaintiffs' Amended Infringement Contentions as to Dr. Reddy's Laboratories, Ltd. and Dr. Reddy's Laboratories, Inc. Regarding the '343 and '462 Patents - filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 01/16/2024) (9) |
| Jan 16, 2024 | 260 | NOTICE OF SERVICE of Defendants' Final Disclosure of Prior Art regarding the 383 and 953 Patents [CONFIDENTIAL] filed by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Ltd..(Gattuso, Dominick) (Entered: 01/16/2024) (2) |
| Jan 12, 2024 | 258 | SO ORDERED, re (291 in 1:22-md-03038-CFC, 257 in 1:22-cv-00294-CFC) Stipulation Regarding Authenticity and Business Record Status of Documents, filed by Novo Nordisk A/S, Novo Nordisk Inc. Signed by Judge Colm F. Connolly on 1/12/2024. Associated Cases: 1:22-cv-00294-CFC, 1:22-md-03038-CFC (kmd) (Entered: 01/12/2024) (6) |
| Jan 11, 2024 | 257 | Joint STIPULATION and [Proposed] Order Regarding Authenticity and Business Record Status of Documents by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 01/11/2024) (6) |
| Jan 10, 2024 | 252 | STIPULATION and [Proposed] Order Regarding Authenticity and Business Record Status of Documents (as to Defendant Mylan Pharmaceuticals Inc.) - by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 01/10/2024) (9) |
| Jan 10, 2024 | 253 | SO ORDERED, re (252 in 1:22-cv-00294-CFC, 285 in 1:22-md-03038-CFC, 179 in 1:22-cv-01040-CFC) Stipulation Regarding Authenticity and Business Record Status of Documents (as to Defendant Mylan Pharmaceuticals Inc.), filed by Novo Nordisk A/S, Novo Nordisk Inc. Ordered by Judge Colm F. Connolly on 1/10/2024. Associated Cases: 1:22-cv-00294-CFC, 1:22-cv-01040-CFC, 1:22-md-03038-CFC (kmd) (Entered: 01/10/2024) (9) |
| Jan 10, 2024 | 254 | STIPULATION and [Proposed] Order of Dismissal Among Novo Nordisk Inc., Novo Nordisk A/S, and Alvogen Inc. - by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 01/10/2024) (3) |
| Jan 10, 2024 | 255 | SO ORDERED, re (287 in 1:22-md-03038-CFC, 254 in 1:22-cv-00294-CFC) Stipulation of Dismissal Among Novo Nordisk Inc., Novo Nordisk A/S, and Alvogen Inc. filed by Novo Nordisk A/S, Novo Nordisk Inc. Signed by Judge Colm F. Connolly on 1/10/2024. Associated Cases: 1:22-cv-00294-CFC, 1:22-cv-00299-CFC, 1:22-md-03038-CFC (kmd) (Entered: 01/10/2024) (3) |
| Jan 10, 2024 | 256 | NOTICE OF SERVICE of Defendants' Supplemental Preliminary Disclosure of Prior Art Regarding the '383 and '953 Patents filed by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Ltd..(Gattuso, Dominick) (Entered: 01/10/2024) (2) |
| Dec 27, 2023 | 251 | SO ORDERED, re (250 in 1:22-cv-00294-CFC, 283 in 1:22-md-03038-CFC) Stipulation Regarding Authenticity and Business Record Status of Documents (as to Defendants Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc., and Zydus Lifesciences Limited), filed by Novo Nordisk A/S, Novo Nordisk Inc. Signed by Judge Colm F. Connolly on 12/27/2023. Associated Cases: 1:22-md-03038-CFC, 1:22-cv-00294-CFC (kmd) (Entered: 12/27/2023) (7) |
| Dec 21, 2023 | 250 | STIPULATION and [Proposed] Order Regarding Authenticity and Business Record Status of Documents (as to Defendants Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc., and Zydus Lifesciences Limited) - by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 12/21/2023) (7) |
| Dec 19, 2023 | 249 | SO ORDERED, re (248 in 1:22-cv-00294-CFC, 281 in 1:22-md-03038-CFC) Stipulation Regarding Authenticity and Business Record Status of Documents, filed by Novo Nordisk A/S, Novo Nordisk Inc. Signed by Judge Colm F. Connolly on 12/19/2023. Associated Cases: 1:22-md-03038-CFC, 1:22-cv-00294-CFC (kmd) (Entered: 12/19/2023) (7) |
| Dec 18, 2023 | 248 | Joint STIPULATION and [Proposed] Order Regarding Authenticity and Business Record Status of Documents by Novo Nordisk A/S, Novo Nordisk Inc.. (Egan, Brian) (Entered: 12/18/2023) (7) |
| Dec 14, 2023 | 247 | SO ORDERED, re (278 in 1:22-md-03038-CFC, 245 in 1:22-cv-00294-CFC) Stipulation Regarding Authenticity and Business Record Status of Documents (as to Defendants Dr. Reddy's Laboratories, Ltd. and Dr. Reddy's Laboratories, Inc.), filed by Novo Nordisk A/S, Novo Nordisk Inc. Signed by Judge Colm F. Connolly on 12/14/2023. Associated Cases: 1:22-cv-00294-CFC, 1:22-md-03038-CFC(kmd) (Entered: 12/14/2023) (7) |
| Dec 13, 2023 | 244 | STIPULATION and [Proposed] Order Further Amending Scheduling Order by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Ltd.. (Gattuso, Dominick) (Entered: 12/13/2023) (5) |
| Dec 13, 2023 | 245 | STIPULATION and [Proposed] Order Regarding Authenticity and Business Record Status of Documents (as to Defendants Dr. Reddy's Laboratories, Ltd. and Dr. Reddy's Laboratories, Inc.) - by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 12/13/2023) (7) |
| Dec 13, 2023 | 246 | SO ORDERED, re (277 in 1:22-md-03038-CFC, 244 in 1:22-cv-00294-CFC, 175 in 1:22-cv-01040-CFC) Stipulation Further Amending Scheduling Order, filed by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Ltd. Signed by Judge Colm F. Connolly on 12/13/2023. Associated Cases: 1:22-cv-00294-CFC, 1:22-cv-01040-CFC, 1:22-md-03038-CFC (kmd) (Entered: 12/13/2023) (5) |
| Dec 12, 2023 | 243 | REDACTED VERSION of (271 in 1:22-md-03038-CFC, 239 in 1:22-cv-00294-CFC) Stipulation of Dismissal by Sun Pharmaceutical Industries Ltd., Sun Pharmaceuticals Industries Inc., Sun Pharmaceutical Industries Inc.. (Farnan, Kelly) (Entered: 12/12/2023) (3) |
| Dec 11, 2023 | 242 | SUPPLEMENTAL CLAIM CONSTRUCTION ORDER re (274 in 1:22-md-03038-CFC, 173 in 1:22-cv-01040-CFC, 241 in 1:22-cv-00294-CFC) Letter, ORDER, terminating Deadlines/Hearings: The Supplemental Markman briefing deadlines and the January 11, 2024 Supplemental Markman hearing are vacated. Signed by Judge Colm F. Connolly on 12/11/2023. Associated Cases: 1:22-md-03038-CFC, 1:22-cv-00294-CFC, 1:22-cv-01040-CFC(nmf) (Entered: 12/11/2023) (4) |
| Dec 8, 2023 | 241 | Letter to The Honorable Colm F. COnnolly from Travis Murray regarding remaining claim construction terms in dispute. (Attachments: # 1 [Proposed] Supplemental Claim Construction Order)(Murray, Travis) (Entered: 12/08/2023) (0) |
| Dec 5, 2023 | 239 | [SEALED] STIPULATION of Dismissal and [Proposed] Order as to Sun Regarding the '239 and '154 Patents by Sun Pharmaceutical Industries Ltd., Sun Pharmaceuticals Industries Inc., Sun Pharmaceutical Industries Inc.. (Farnan, Kelly) (Entered: 12/05/2023) (0) |
| Dec 5, 2023 | 240 | [SEALED] SO ORDERED, re (271 in 1:22-md-03038-CFC, 239 in 1:22-cv-00294-CFC) Stipulation of Dismissal as to Sun Regarding the '239 and '154 Patents, filed by Sun Pharmaceutical Industries Inc., Sun Pharmaceutical Industries Ltd., Sun Pharmaceuticals Industries Inc. Signed by Judge Colm F. Connolly on 12/5/2023. This order has been emailed to local counsel. Associated Cases: 1:22-cv-00294-CFC, 1:22-md-03038-CFC (kmd) (Entered: 12/05/2023) (0) |
| Dec 4, 2023 | 237 | STIPULATION and [Proposed] Order Regarding Depositions of DRL Foreign Witness - by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 12/04/2023) (4) |
| Dec 4, 2023 | 238 | SO ORDERED, re (237 in 1:22-cv-00294-CFC, 269 in 1:22-md-03038-CFC) Stipulation Regarding Depositions of DRL Foreign Witness, filed by Novo Nordisk A/S, Novo Nordisk Inc. Signed by Judge Colm F. Connolly on 12/4/2023. Associated Cases: 1:22-cv-00294-CFC, 1:22-md-03038-CFC(kmd) (Entered: 12/04/2023) (4) |
| Dec 1, 2023 | 236 | SO ORDERED, re (267 in 1:22-md-03038-CFC, 170 in 1:22-cv-01040-CFC, 235 in 1:22-cv-00294-CFC) Stipulation Amending Scheduling Order, filed by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Ltd. Resetting Scheduling Order Deadlines: Fact Discovery completed by 12/15/2023. Opening Expert Reports due by 3/1/2024. Rebuttal Expert Reports due by 4/5/2024. Expert Discovery due by 6/7/2024. Signed by Judge Colm F. Connolly on 12/1/2023. Associated Cases: 1:22-cv-00294-CFC, 1:22-cv-01040-CFC, 1:22-md-03038-CFC(kmd) (Entered: 12/01/2023) (7) |
| Nov 30, 2023 | 235 | STIPULATION Amending Scheduling Order with [Proposed] Order by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Ltd.. (Gattuso, Dominick) (Entered: 11/30/2023) (7) |
| Nov 20, 2023 | 231 | NOTICE to Take Deposition of Pradeep Patil on November 30, 2023 filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 11/20/2023) (4) |
| Nov 20, 2023 | 232 | STIPULATION and [Proposed] Order Regarding Depositions of Certain Sun Foreign Witnesses by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 11/20/2023) (4) |
| Nov 20, 2023 | 233 | SO ORDERED, re (167 in 1:22-cv-01040-CFC, 261 in 1:22-md-03038-CFC, 230 in 1:22-cv-00294-CFC) STIPULATION TO EXTEND TIME for Supplemental Claim Construction Briefs and Expert Declarations to December 11, 2023, filed by Novo Nordisk A/S, Novo Nordisk Inc. Reset Deadlines for Claim Construction Briefing and Markman Hearing: Joint Claim Construction Brief due by 12/11/2023. Signed by Judge Colm F. Connolly on 11/20/2023. Associated Cases: 1:22-md-03038-CFC, 1:22-cv-00294-CFC, 1:22-cv-01040-CFC(kmd) (Entered: 11/20/2023) (4) |
| Nov 20, 2023 | 234 | SO ORDERED, re (263 in 1:22-md-03038-CFC, 232 in 1:22-cv-00294-CFC) Stipulation Regarding Depositions of Certain Sun Foreign Witnesses, filed by Novo Nordisk A/S, Novo Nordisk Inc. Signed by Judge Colm F. Connolly on 11/20/2023. Associated Cases: 1:22-md-03038-CFC, 1:22-cv-00294-CFC(kmd) (Entered: 11/20/2023) (4) |
| Nov 17, 2023 | 230 | STIPULATION TO EXTEND TIME for Supplemental Claim Construction Briefs and Expert Declarations to December 11, 2023 - filed by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 11/17/2023) (4) |
| Nov 10, 2023 | 229 | NOTICE OF SERVICE of (1) Defendants Rio Biopharmaceuticals Inc. and EMS S/A's Responses and Objections to Plaintiffs' Fourth Set of Collective Interrogatories (Nos. 15-16) and; (2) Defendants Rio Biopharmaceuticals and EMS S/A's Responses and Objections to Plaintiffs' First Set of Collective Requests for Admission (Nos. 1-24) filed by EMS S/A, Mylan Pharmaceuticals Inc., Novo Nordisk A/S, Novo Nordisk Inc., Ozempic (Semaglutide) Patent Litigation, Rio Biopharmaceuticals, Inc..(Dorsney, Kenneth) (Entered: 11/10/2023) (3) |
| Nov 6, 2023 | 226 | SO ORDERED, re (222 in 1:22-cv-00294-CFC, 251 in 1:22-md-03038-CFC) Stipulation Regarding Infringement of U.S. Patent Nos. 8,129,343 and 10,335,462, filed by Novo Nordisk A/S, Novo Nordisk Inc. Signed by Judge Colm F. Connolly on 11/6/2023. Associated Cases: 1:22-md-03038-CFC, 1:22-cv-00294-CFC(kmd) (Entered: 11/06/2023) (6) |
| Nov 6, 2023 | 227 | NOTICE OF SERVICE of Defendants' Supplemental Invalidity Contentions filed by Sun Pharmaceutical Industries Ltd., Sun Pharmaceuticals Industries Inc., Sun Pharmaceutical Industries Inc..(Metzler, Sara) (Entered: 11/06/2023) (2) |
| Nov 6, 2023 | 228 | NOTICE OF SERVICE of (1) Sun's Responses and Objections to Plaintiffs' First Set of Requests for Admission to Sun Defendants (Nos. 1-61); (2) Sun's Responses and Objections to Plaintiffs' First Set of Collective Requests for Admission (Nos. 1-24); and (3) Sun's Responses and Objections to Plaintiffs' Fourth Set of Collective Interrogatories (Nos. 15-16) filed by Sun Pharmaceutical Industries Ltd., Sun Pharmaceuticals Industries Inc., Sun Pharmaceutical Industries Inc..(Metzler, Sara) (Entered: 11/06/2023) (3) |
| Nov 3, 2023 | 220 | NOTICE OF SERVICE of Plaintiffs' Responses and Objections to Defendants' Third Set of Requests for Production (Nos. 29-32) - filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 11/03/2023) (11) |
| Nov 3, 2023 | 221 | NOTICE OF SERVICE of (1) Alvogen, Inc.s Responses and Objections to Plaintiffs Fourth Set of Collective Interrogatories (Nos. 15 16), (2) Defendant Alvogen, Inc.s Objections and Responses to Plaintiffs First Set of Requests for Admission to Alvogen, Inc. (Nos. 1 56) and (3) Defendant Alvogen, Inc.s Objections and Responses to Plaintiffs First Set of Collective Requests for Admission to Alvogen, Inc. (Nos. 1 24) filed by Alvogen, Inc..(Keller, Karen) (Entered: 11/03/2023) (3) |
| Nov 3, 2023 | 222 | STIPULATION and [Proposed] Order Regarding Infringement of U.S. Patent Nos. 8,129,343 and 10,335,462 by Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc., and Zydus Lifesciences Limited - by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 11/03/2023) (6) |
| Nov 3, 2023 | 223 | NOTICE OF SERVICE of Defendant Rio Biopharmaceuticals Inc. and EMS S/A's Responses and Objections to Plaintiffs' First Set of Requests for Admission to Rio (Nos. 1-48) filed by EMS S/A, Rio Biopharmaceuticals, Inc..(Dorsney, Kenneth) (Entered: 11/03/2023) (3) |
| Nov 3, 2023 | 224 | NOTICE OF SERVICE of (i) Defendants Dr. Reddy's Laboratories, Ltd. and Dr. Reddy's Laboratories, Inc.'s Objections and Responses to Plaintiff's First Set of Requests for Admission (Nos. 169) [CONFIDENTIAL]; (ii) DRL's Responses and Objection to Plaintiffs' Fourth Set of Collective Interrogatories to Plaintiffs (Nos. 1516); and; (iii) Defendants Dr. Reddy's Laboratories, Ltd. and Dr. Reddy's Laboratories, Inc.'s Objections and Responses to Plaintiffs' First Set of Collective Requests for Admission (Nos. 1-24) [CONFIDENTIAL] filed by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Ltd..(Gattuso, Dominick) (Entered: 11/03/2023) (3) |
| Nov 3, 2023 | 225 | NOTICE OF SERVICE of 1) Defendants Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc., and Zydus Lifesciences Limited's Objections and Responses to Plaintiffs' Fourth Set of Collective Interrogatories to Defendants (Nos. 15-16); and 2) Defendants Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc., and Zydus Lifesciences Limited Objections and Responses to Plaintiffs' First Set of Requests for Admission (No. 10) filed by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC.(Stombaugh, Alexis) (Entered: 11/03/2023) (3) |
| Nov 2, 2023 | 218 | NOTICE OF SERVICE of (1) Plaintiffs' Responses and Objections to Defendants' Second Set of Requests for Production (Nos. 24-28); (2) Plaintiffs' Responses and Objections to Defendants' Second Set of Interrogatories (Nos. 5-7); and (3) Plaintiffs' Responses and Objections to Defendants' First Set of Joint Requests for Admission to Plaintiffs (Nos. 1-25) filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 11/02/2023) (11) |
| Nov 2, 2023 | 219 | NOTICE OF SERVICE of Plaintiffs' Responses and Objections to Defendants Rio Biopharmaceuticals Inc. and Ems S/A's First Set of Requests for Admission to Plaintiffs (Nos. 1-14) - filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 11/02/2023) (3) |
| Nov 1, 2023 | 217 | NOTICE OF SERVICE of Plaintiffs' Responses and Objections to Alvogen, Inc.'s First Set of Requests for Admission (Nos. 1-15) - filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 11/01/2023) (3) |
| Oct 20, 2023 | 215 | NOTICE OF SERVICE of Alvogen, Inc.s Amended Rule 26(a)(1) Initial Disclosures filed by Alvogen, Inc..(Keller, Karen) (Entered: 10/20/2023) (3) |
| Oct 20, 2023 | 216 | Letter to The Honorable Colm F. Connolly from Travis J. Murray regarding expert testimony - re (157 in 1:22-md-03038-CFC, 157 in 1:22-md-03038-CFC) Order,, Set Deadlines/Hearings,. (Murray, Travis) (Entered: 10/20/2023) (2) |
| Oct 19, 2023 | 214 | SO ORDERED, re (239 in 1:22-md-03038-CFC, 157 in 1:22-cv-01040-CFC, 213 in 1:22-cv-00294-CFC) Stipulation Extending Deadline for Certain Fact Discovery Deadlines, filed by Novo Nordisk A/S, Novo Nordisk Inc. Signed by Judge Colm F. Connolly on 10/19/2023. Associated Cases: 1:22-md-03038-CFC, 1:22-cv-00294-CFC, 1:22-cv-01040-CFC (kmd) (Entered: 10/19/2023) (5) |
| Oct 18, 2023 | 213 | Joint STIPULATION and [Proposed] Order Extending Deadline for Certain Fact Discovery Deadlines - by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 10/18/2023) (5) |
| Oct 17, 2023 | 212 | NOTICE to Take Deposition of Yaswanth Polimetla on October 27, 2023 filed by Novo Nordisk A/S, Novo Nordisk Inc..(Egan, Brian) (Entered: 10/17/2023) (4) |
| Oct 12, 2023 | 211 | MOTION for Pro Hac Vice Appearance of Attorney Ashley Graham and Hannah M. Shankman of Winston & Strawn LLP - filed by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Ltd.. (Gattuso, Dominick) (Entered: 10/12/2023) (5) |
| Oct 6, 2023 | 210 | NOTICE OF SERVICE of Plaintiffs' Responses and Objections to Defendants' Second Notice of Deposition of Novo Nordisk Inc. and Novo Nordisk A/S Pursuant to Fed. R. Civ. P. 30(b)(6) - filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 10/06/2023) (11) |
| Sep 25, 2023 | 209 | NOTICE OF SERVICE of Plaintiffs' Responses and Objections to Defendants' Notice of Deposition of Novo Nordisk Inc. and Novo Nordisk A/S Pursuant to Fed. R. Civ. P. 30(b)(6) - filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 09/25/2023) (11) |
| Sep 21, 2023 | 208 | NOTICE OF SERVICE of Defendants' Third Set of Requests for Production to Plaintiffs (Nos. 29-32) filed by Sun Pharmaceutical Industries Ltd., Sun Pharmaceuticals Industries Inc., Sun Pharmaceutical Industries Inc..(Metzler, Sara) (Entered: 09/21/2023) (2) |
| Sep 20, 2023 | 205 | NOTICE OF SERVICE of (i) DRL's Amended Objections and Responses to Plaintiffs' First Set of Collective Interrogatories to Defendants (Nos. 1-12) and; (ii) DRLs First Amended Initial Disclosures Pursuant to Rule 26(a)(1) filed by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Ltd..(Gattuso, Dominick) (Entered: 09/20/2023) (2) |
| Sep 20, 2023 | 206 | MOTION for Pro Hac Vice Appearance of Attorney Silvia M. Medina - filed by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 09/20/2023) (9) |
| Sep 20, 2023 | 207 | NOTICE OF SERVICE of (1) Plaintiffs' First Set of Collective Requests for Admission to Defendants (Nos. 1-24), (2) Plaintiffs' Fourth Set of Collective Interrogatories to Defendants (Nos. 15-16), (3) Plaintiffs' First Set of Requests for Admission to Defendants Dr. Reddy's Laboratories, Ltd. and Dr. Reddy's Laboratories, Inc. (Nos. 1-69), (4) Plaintiffs' First Set of Requests for Admission to Defendant Alvogen, Inc. (Nos. 1-56), (5) Plaintiffs' First Set of Requests for Admission to Defendant Mylan Pharmaceuticals, Inc. (Nos. 1-82), (6) Plaintiffs' First Set of Requests for Admission to Defendants Rio Biopharmaceuticals Inc. and EMS S/A (Nos. 1-48), (7) Plaintiffs' First Set of Requests for Admission to Defendants Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc., and Zydus Lifesciences Limited (Nos. 1-58), and (8) Plaintiffs' First Set of Requests for Admission to Defendants Sun Pharmaceutical Industries Ltd. and Sun Pharmaceutical Industries, Inc. (Nos. 1-61) - filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 09/20/2023) (17) |
| Sep 19, 2023 | 201 | NOTICE OF SERVICE of (i) Defendants' First Set of Joint Requests for Admission to Plaintiffs (Nos. 1-25); and, (ii) Defendants' Second Set of Interrogatories to Plaintiffs (Nos. 5-7) filed by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Ltd..(Gattuso, Dominick) (Entered: 09/19/2023) (3) |
| Sep 19, 2023 | 202 | NOTICE OF SERVICE of DRL's Responses and Objections to Plaintiff's Notice of Deposition under Fed. R. Civ. P. 30(b)(6) [CONFIDENTIAL] filed by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Ltd..(Gattuso, Dominick) (Entered: 09/19/2023) (2) |
| Sep 19, 2023 | 203 | NOTICE OF SERVICE of Defendants Rio Biopharmaceuticals Inc. and EMS S/A's First Set of Requests for Admission to Plaintiffs (Nos. 1-14) filed by EMS S/A, Rio Biopharmaceuticals, Inc..(Hitch, Cortlan) (Entered: 09/19/2023) (3) |
| Sep 19, 2023 | 204 | NOTICE OF SERVICE of Defendants' Response to Plaintiffs' Notice of Deposition of Defendants Sun Pharmaceutical Industries Ltd. and Sun Pharmaceutical Industries Inc. Pursuant to Fed. R. Civ. P. 30(b)(6) filed by Sun Pharmaceutical Industries Ltd., Sun Pharmaceuticals Industries Inc., Sun Pharmaceutical Industries Inc..(Farnan, Kelly) (Entered: 09/19/2023) (2) |
| Sep 18, 2023 | 200 | NOTICE OF SERVICE of Alvogen, Inc.'s First Set of Requests for Admission (Nos. 1-15) filed by Alvogen, Inc..(Hoeschen, Nathan) (Entered: 09/18/2023) (3) |
| Sep 15, 2023 | 199 | NOTICE OF SERVICE of Defendant Alvogen, Inc.'s Objections and Responses to Plaintiffs' Notice of Deposition under Fed. R. Civ. P. 30(b)(6) filed by Alvogen, Inc..(Keller, Karen) (Entered: 09/15/2023) (3) |
| Sep 13, 2023 | 198 | MOTION for Pro Hac Vice Appearance of Attorney Vanessa Park-Thompson, Allie Cohen Dolloff, Ryan A. Haddad, Retley G. Locke Jr., Michael Yoon, Michelle E. Irwin and Adeline Miller - filed by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 09/13/2023) (14) |
| Sep 7, 2023 | 177 | NOTICE to Take Deposition of Siyawosh Moghaddam (Alvogen) on October 9, 2023 filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 09/07/2023) (3) |
| Sep 7, 2023 | 178 | NOTICE to Take Deposition of Jyoti Sachdeva (Alvogen) on October 10, 2023 filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 09/07/2023) (3) |
| Sep 7, 2023 | 179 | NOTICE to Take Deposition of Karuna Dixit on October 11, 2023 filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 09/07/2023) (3) |
| Sep 7, 2023 | 180 | NOTICE to Take Deposition of Erika Roers (Alvogen) on October 12, 2023 filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 09/07/2023) (3) |
| Sep 7, 2023 | 181 | NOTICE to Take Deposition of Vineet Yadav (Alvogen) on October 13, 2023 filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 09/07/2023) (3) |
| Sep 7, 2023 | 182 | NOTICE to Take Deposition of Jaya Lakshmi Ayyagari (DRL) on October 2, 2023 filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 09/07/2023) (3) |
| Sep 7, 2023 | 183 | NOTICE to Take Deposition of Smiti Kumar (DRL) on October 3, 2023 filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 09/07/2023) (3) |
| Sep 7, 2023 | 184 | NOTICE to Take Deposition of Ashok Tyagi (DRL) on October 4, 2023 filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 09/07/2023) (3) |
| Sep 7, 2023 | 185 | NOTICE to Take Deposition of Sushil Kisan Kurade (DRL) on October 5, 2023 filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 09/07/2023) (3) |
| Sep 7, 2023 | 186 | NOTICE to Take Deposition of Ananda Sandhya K (DRL) on October 6, 2023 filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 09/07/2023) (3) |
| Sep 7, 2023 | 187 | NOTICE to Take Deposition of Daniel Salazar (Rio) on September 15, 2023 filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 09/07/2023) (3) |
| Sep 7, 2023 | 188 | NOTICE to Take Deposition of Wilberto Maldonado (Rio) on September 18, 2023 filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 09/07/2023) (3) |
| Sep 7, 2023 | 189 | NOTICE to Take Deposition of Ana Paula Rodrigues (Rio) on September 19, 2023 filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 09/07/2023) (3) |
| Sep 7, 2023 | 190 | NOTICE to Take Deposition of Srinivas Gurram (Zydus) on September 20, 2023 filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 09/07/2023) (3) |
| Sep 7, 2023 | 191 | NOTICE to Take Deposition of Debjani Singh on September 21, 2023 filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 09/07/2023) (3) |
| Sep 7, 2023 | 192 | NOTICE to Take Deposition of Tushar Nahata (Zydus) on September 22, 2023 filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 09/07/2023) (3) |
| Sep 7, 2023 | 193 | NOTICE to Take Deposition of Praveen Devakadaksham (Sun) on October 16, 2023 filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 09/07/2023) (4) |
| Sep 7, 2023 | 194 | NOTICE to Take Deposition of Nilesh Patel (Sun) on October 17, 2023 filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 09/07/2023) (4) |
| Sep 7, 2023 | 195 | NOTICE to Take Deposition of Satyashodhan Patil (Sun) on October 18, 2023 filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 09/07/2023) (4) |
| Sep 7, 2023 | 196 | NOTICE to Take Deposition of Krupali Trivedi (Sun) on October 19, 2023 filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 09/07/2023) (4) |
| Sep 7, 2023 | 197 | NOTICE to Take Deposition of Viral Jogani (Sun) on October 20, 2023 filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 09/07/2023) (4) |
| Sep 6, 2023 | 176 | NOTICE OF SERVICE of Defendants Rio Biopharmaceuticals Inc. and EMS S/A's Objections to Plaintiffs' Notice of 30(b)(6) Deposition filed by EMS S/A, Rio Biopharmaceuticals, Inc..(Dorsney, Kenneth) (Entered: 09/06/2023) (2) |
| Sep 5, 2023 | 175 | NOTICE OF SERVICE of Plaintiffs' Final Election of Asserted Claims (Individual Final Elections Served on Each Defendant Group) -- filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 09/05/2023) (9) |
| Aug 28, 2023 | 174 | NOTICE requesting Clerk to remove August Melcher as co-counsel.. (Stombaugh, Alexis) (Entered: 08/28/2023) (3) |
| Aug 24, 2023 | 172 | REDACTED VERSION of (166 in 1:22-cv-00294-CFC, 165 in 1:22-md-03038-CFC) Notice to Take Deposition - by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 08/24/2023) (6) |
| Aug 24, 2023 | 173 | REDACTED VERSION of (166 in 1:22-md-03038-CFC, 167 in 1:22-cv-00294-CFC) Notice to Take Deposition by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 08/24/2023) (7) |
| Aug 23, 2023 | 169 | REDACTED VERSION of (167 in 1:22-md-03038-CFC, 168 in 1:22-cv-00294-CFC) Notice to Take Deposition - by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 08/23/2023) (7) |
| Aug 23, 2023 | 170 | REDACTED VERSION of (165 in 1:22-cv-00294-CFC, 164 in 1:22-md-03038-CFC) Notice to Take Deposition - by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 08/23/2023) (7) |
| Aug 23, 2023 | 171 | REDACTED VERSION of (164 in 1:22-cv-00294-CFC, 163 in 1:22-md-03038-CFC) Notice to Take Deposition - by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 08/23/2023) (6) |
| Aug 17, 2023 | 164 | [SEALED] NOTICE to Take Deposition of Rio Biopharmaceuticals Inc. and EMS S/A on September 14, 2023 filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 08/17/2023) (0) |
| Aug 17, 2023 | 165 | [SEALED] NOTICE to Take Deposition of Alvogen, Inc. on September 18, 2023 filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 08/17/2023) (0) |
| Aug 17, 2023 | 166 | [SEALED] NOTICE to Take Deposition of Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc., and Zydus Lifesciences Limited on September 21, 2023 filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 08/17/2023) (0) |
| Aug 17, 2023 | 167 | [SEALED] NOTICE to Take Deposition of Sun Pharmaceutical Industries Ltd. and Sun Pharmaceutical Industries Inc. on September 25, 2023 filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 08/17/2023) (0) |
| Aug 17, 2023 | 168 | [SEALED] NOTICE to Take Deposition of Dr. Reddy's Laboratories, Ltd. and Dr. Reddy's Laboratories, Inc. on September 28, 2023 filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 08/17/2023) (0) |
| Aug 8, 2023 | 163 | NOTICE OF SERVICE of DRL's First Amended Noninfringement Contentions regarding the 462 Patent (CONFIDENTIAL) filed by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Ltd..(Gattuso, Dominick) (Entered: 08/08/2023) (2) |
| Aug 4, 2023 | 162 | Letter to The Honorable Colm F. Connolly from Travis J. Murray regarding the Court's July 25, 2023 Claim Construction Order - re (113 in 1:22-cv-01040-CFC, 158 in 1:22-cv-00294-CFC, 148 in 1:22-md-03038-CFC) Order,. (Murray, Travis) (Entered: 08/04/2023) (4) |
| Aug 2, 2023 | 161 | NOTICE OF SERVICE of Novo Nordisk's First Amended Responses to Defendants' Initial Invalidity Contentions Regarding U.S. Patent Nos. 8,129,343; 8,536,122; 8,114,833; 8,920,383; 9,775,953; 9,457,154; and 10,335,462 filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 08/02/2023) (12) |
| Jul 31, 2023 | 159 | NOTICE OF SERVICE of (1) Plaintiffs' Third Amended Disclosures Under Paragraph 3 of the District of Delaware Default Standard; and (2) Plaintiffs' Third Amended Disclosures to Defendants Pursuant to Rule 26(a)(1) of the Federal Rules of Civil Procedure (specific sets separately to Sun and Zydus defendant groups) filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 07/31/2023) (6) |
| Jul 31, 2023 | 160 | NOTICE OF SERVICE of (1) Plaintiffs' Second Amended Disclosures Under Paragraph 3 of the District of Delaware Default Standard; and (2) Plaintiffs' Second Amended Disclosures to Defendants Pursuant to Rule 26(a)(1) of the Federal Rules of Civil Procedure specific sets separately to Rio, DRL and Alvogen defendant groups) filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 07/31/2023) (7) |
| Jul 25, 2023 | 158 | CLAIM CONSTRUCTION ORDER re (147 in 1:22-md-03038-CFC, 157 in 1:22-cv-00294-CFC, 112 in 1:22-cv-01040-CFC) Proposed Claim Construction Order. Signed by Judge Colm F. Connolly on 7/25/2023. Associated Cases: 1:22-md-03038-CFC, 1:22-cv-00294-CFC, 1:22-cv-01040-CFC(nmf) (Entered: 07/25/2023) (8) |
| Jul 20, 2023 | 157 | PROPOSED ORDER -- Claim Construction -- by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 07/20/2023) (8) |
| Jul 17, 2023 | 156 | Official Transcript of Markman Hearing held on July 13, 2023 before Chief Judge Connolly. Court Reporter/Transcriber Bonnie Archer, Email: bonnie_archer@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 8/7/2023. Redacted Transcript Deadline set for 8/17/2023. Release of Transcript Restriction set for 10/16/2023. (nmf) (Entered: 07/17/2023) (134) |
| Jul 12, 2023 | 155 | SO ORDERED, re (142 in 1:22-md-03038-CFC, 154 in 1:22-cv-00294-CFC, 107 in 1:22-cv-01040-CFC) Joint MOTION for Exemption of Persons from the District of Delaware's May 15, 2023 Standing Order on Personal Devices, filed by Novo Nordisk A/S, Novo Nordisk Inc. Signed by Judge Colm F. Connolly on 7/12/2023. Associated Cases: 1:22-md-03038-CFC, 1:22-cv-00294-CFC, 1:22-cv-01040-CFC(kmd) (Entered: 07/12/2023) (6) |
| Jul 11, 2023 | 154 | Joint MOTION for Exemption of Persons from the District of Delaware's May 15, 2023 Standing Order on Personal Devices - filed by Novo Nordisk A/S, Novo Nordisk Inc.. (Egan, Brian) (Entered: 07/11/2023) (6) |
| Jun 26, 2023 | 153 | NOTICE OF SERVICE of (1) Plaintiffs' First Amended Disclosures to Defendant Alvogen, Inc. Under Paragraph 3 of the District of Delaware Default Standard, (2) Plaintiffs' First Amended Disclosures to Defendant Alvogen, Inc. Pursuant to Rule 26(a)(1) of the Federal Rules of Civil Procedure, (3) Plaintiffs' First Amended Disclosures to Defendants Dr. Reddy's Laboratories, Ltd. and Dr. Reddy's Laboratories, Inc. Under Paragraph 3 of the District of Delaware Default Standard, (4) Plaintiffs' First Amended Disclosures to Defendants Dr. Reddy's Laboratories, Ltd. and Dr. Reddy's Laboratories, Inc. Pursuant to Rule 26(a)(1) of the Federal Rules of Civil Procedure, (5) Plaintiffs' First Amended Disclosures to Defendants Rio Biopharmaceuticals Inc. and EMS S/A Under Paragraph 3 of the District of Delaware Default Standard, (6) Plaintiffs' First Amended Disclosures to Defendants Rio Biopharmaceuticals Inc. and EMS S/A Pursuant to Rule 26(a)(1) of the Federal Rules of Civil Procedure, (7) Plaintiffs' Second Amended Disclosures to Defendants Sun Pharmaceutical Industries Ltd. and Sun Pharmaceutical Industries, Inc. Under Paragraph 3 of the District of Delaware Default Standard, (8) Plaintiffs' Second Amended Disclosures to Defendants Sun Pharmaceutical Industries Ltd. and Sun Pharmaceutical Industries, Inc. Pursuant to Rule 26(a)(1) of the Federal Rules of Civil Procedure, (9) Plaintiffs' Second Amended Disclosures to Defendants Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc., and Zydus Lifesciences Limited Under Paragraph 3 of the District of Delaware Default Standard, and (10) Plaintiffs' Second Amended Disclosures to Defendants Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc., and Zydus Lifesciences Limited Pursuant to Rule 26(a)(1) of the Federal Rules of Civil Procedure - filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 06/26/2023) (11) |
| Jun 23, 2023 | 151 | STIPULATION TO EXTEND TIME Joint Stipulation Extending Deadline for Substantial Completion of Document Production to June 30, 2023 - filed by EMS S/A, Rio Biopharmaceuticals, Inc.. (Dorsney, Kenneth) (Entered: 06/23/2023) (6) |
| Jun 23, 2023 | 152 | SO ORDERED, re (104 in 1:22-cv-01040-CFC, 138 in 1:22-md-03038-CFC, 151 in 1:22-cv-00294-CFC) STIPULATION TO EXTEND TIME Joint Stipulation Extending Deadline for Substantial Completion of Document Production to June 30, 2023, filed by Rio Biopharmaceuticals, Inc., EMS S/A. Setting Scheduling Order Deadlines: Discovery due by 6/30/2023. Signed by Judge Colm F. Connolly on 6/23/2023. Associated Cases: 1:22-cv-01040-CFC, 1:22-cv-00294-CFC, 1:22-md-03038-CFC (kmd) (Entered: 06/23/2023) (6) |
| Jun 8, 2023 | 150 | REDACTED VERSION of (148 in 1:22-cv-00294-CFC, 135 in 1:22-md-03038-CFC) Stipulation - by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 06/08/2023) (3) |
| Jun 2, 2023 | 149 | [SEALED] SO ORDERED, re (148 in 1:22-cv-00294-CFC, 135 in 1:22-md-03038-CFC) Stipulation of Dismissal as to Rio Biopharmaceuticals Inc. and EMS S/A Regarding the '154 Patent, filed by Novo Nordisk A/S, Novo Nordisk Inc. Signed by Judge Colm F. Connolly on 6/2/2023.This order has been emailed to local counsel. Associated Cases: 1:22-cv-00294-CFC, 1:22-md-03038-CFC(kmd) (Entered: 06/02/2023) (0) |
| Jun 1, 2023 | 148 | [SEALED] STIPULATION and [Proposed] Order of Dismissal as to Rio Biopharmaceuticals Inc. and EMS S/A Regarding the '154 Patent - by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 06/01/2023) (0) |
| May 30, 2023 | 147 | SO ORDERED, re (133 in 1:22-md-03038-CFC, 146 in 1:22-cv-00294-CFC, 102 in 1:22-cv-01040-CFC) STIPULATION TO EXTEND TIME for Substantial Completion of Document Production to June 23, 2023, filed by Novo Nordisk A/S, Novo Nordisk Inc. Setting Deadlines: Discovery due by 6/23/2023. Signed by Judge Colm F. Connolly on 5/30/2023. Associated Cases: 1:22-md-03038-CFC, 1:22-cv-00294-CFC, 1:22-cv-01040-CFC(kmd) (Entered: 05/30/2023) (5) |
| May 26, 2023 | 146 | STIPULATION TO EXTEND TIME for Substantial Completion of Document Production to June 23, 2023 - filed by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 05/26/2023) (5) |
| May 23, 2023 | 145 | CLAIM Construction Chart by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 05/23/2023) (30) |
| May 19, 2023 | 144 | STIPULATION and [Proposed] Order to Extend the Deadline to Submit Amended Joint Claim Construction Chart to and including May 23, 2023 by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 05/19/2023) (5) |
| May 16, 2023 | 143 | REDACTED VERSION of (125 in 1:22-md-03038-CFC, 139 in 1:22-cv-00294-CFC) Stipulation of Dismissal, as to Dr. Reddy's Laboratories, Ltd. and Dr. Reddy's Laboratories, Inc. Regarding the '154, '239, '611, '155, '063, and '363 Patents - by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 05/16/2023) (4) |
| May 15, 2023 | 142 | SO ORDERED, re (98 in 1:22-cv-01040-CFC, 141 in 1:22-cv-00294-CFC, 128 in 1:22-md-03038-CFC) STIPULATION TO EXTEND TIME to submit an amended joint claim construction chart to May 19, 2023 filed by Novo Nordisk A/S, Novo Nordisk Inc. Signed by Judge Colm F. Connolly on 5/15/2023. Associated Cases: 1:22-md-03038-CFC, 1:22-cv-00294-CFC, 1:22-cv-01040-CFC(nmf) (Entered: 05/15/2023) (4) |
| May 12, 2023 | 141 | STIPULATION TO EXTEND TIME to submit an amended joint claim construction chart to May 19, 2023 - filed by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 05/12/2023) (4) |
| May 11, 2023 | 140 | [SEALED] SO ORDERED, re (125 in 1:22-md-03038-CFC, 139 in 1:22-cv-00294-CFC) Stipulation of Dismissal As To Dr. Reddy's Laboratories, Ltd. And Dr. Reddy's Laboratories, Inc. Regarding The '154, '239, '611, '155, '063, And '363 Patents, filed by Novo Nordisk A/S, Novo Nordisk Inc. Signed by Judge Colm F. Connolly on 5/11/2023.This order has been emailed to local counsel. Associated Cases: 1:22-md-03038-CFC, 1:22-cv-00294-CFC(kmd) (Entered: 05/11/2023) (0) |
| May 10, 2023 | 139 | [SEALED] STIPULATION of Dismissal As To Dr. Reddy's Laboratories, Ltd. And Dr. Reddy's Laboratories, Inc. Regarding The '154, '239, '611, '155, '063, And '363 Patents by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 05/10/2023) (0) |
| May 8, 2023 | 138 | REDACTED VERSION of (137 in 1:22-cv-00294-CFC, 123 in 1:22-md-03038-CFC, 95 in 1:22-cv-01040-CFC) Appendix, by Novo Nordisk A/S, Novo Nordisk Inc.. (Attachments: # 1 Exs. A-L, # 2 Exs. 1-14)(Murray, Travis) (Entered: 05/08/2023) (Main Document) (13) |
| May 8, 2023 | 138 | REDACTED VERSION of (137 in 1:22-cv-00294-CFC, 123 in 1:22-md-03038-CFC, 95 in 1:22-cv-01040-CFC) Appendix, by Novo Nordisk A/S, Novo Nordisk Inc.. (Attachments: # 1 Exs. A-L, # 2 Exs. 1-14)(Murray, Travis) (Entered: 05/08/2023) (Exs. A-L) (30) |
| May 8, 2023 | 138 | REDACTED VERSION of (137 in 1:22-cv-00294-CFC, 123 in 1:22-md-03038-CFC, 95 in 1:22-cv-01040-CFC) Appendix, by Novo Nordisk A/S, Novo Nordisk Inc.. (Attachments: # 1 Exs. A-L, # 2 Exs. 1-14)(Murray, Travis) (Entered: 05/08/2023) (Exs. 1-14) (30) |
| May 5, 2023 | 137 | [SEALED] Joint APPENDIX re (119 in 1:22-md-03038-CFC) Joint Claim Construction Brief, (91 in 1:22-cv-01040-CFC) Joint Claim Construction Brief, (136 in 1:22-cv-00294-CFC) Joint Claim Construction Brief - by Novo Nordisk A/S, Novo Nordisk Inc.. (Attachments: # 1 Exs. A-L, # 2 Exs. 1-14)(Murray, Travis) (Entered: 05/05/2023) (0) |
| May 1, 2023 | 136 | JOINT CLAIM CONSTRUCTION BRIEF - filed by Novo Nordisk Inc., Novo Nordisk A/S. (Murray, Travis) (Entered: 05/01/2023) (30) |
| Apr 27, 2023 | 135 | NOTICE OF SERVICE of Defendants' Sur-Reply Claim Construction Brief filed by Mylan Pharmaceuticals Inc..(Stamoulis, Stamatios) (Entered: 04/27/2023) (2) |
| Apr 25, 2023 | 134 | NOTICE OF SERVICE of Alvogen, Inc.'s First Amended and Supplemental Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery filed by Alvogen, Inc..(DiBenedetto, Emily) (Entered: 04/25/2023) (2) |
| Apr 6, 2023 | 133 | NOTICE OF SERVICE of (1) Novo Nordisk's Reply Claim Construction Brief and (2) Declaration of Laura T. Moran in Support of Novo Nordisk A/S and Novo Nordisk Inc.'s Reply Claim Construction Brief - filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 04/06/2023) (12) |
| Mar 17, 2023 | 132 | NOTICE OF SERVICE of copies of (i) Defendants' Answering Claim Construction Brief; and, (ii) Declaration of Karl R. Leinsing, MSME, PE filed by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Ltd..(Gattuso, Dominick) (Entered: 03/17/2023) (2) |
| Mar 7, 2023 | 130 | NOTICE OF SERVICE of Plaintiffs' Second Supplemental Disclosure of Asserted Patents and Claims as to Alvogen filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 03/07/2023) (3) |
| Mar 7, 2023 | 131 | NOTICE OF SERVICE of Plaintiffs' Second Supplemental Disclosure of Asserted Patents and Claims as to DRL Defendants filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 03/07/2023) (3) |
| Mar 6, 2023 | 129 | NOTICE OF SERVICE of Plaintiffs' First Amended Infringement Contentions Regarding the '343 Patent (Individual Sets Served on Each Defendant Group) - filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 03/06/2023) (12) |
| Feb 24, 2023 | 128 | NOTICE OF SERVICE of Novo Nordisk's Opening Claim Construction Brief - filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 02/24/2023) (12) |
| Feb 9, 2023 | 126 | NOTICE OF SERVICE of Plaintiffs' Second Supplemental Disclosure of Asserted Patents and Claims as to Zydus Defendants filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 02/09/2023) (4) |
| Feb 9, 2023 | 127 | NOTICE OF SERVICE of Plaintiffs' First Supplemental Disclosure of Asserted Patents and Claims as to RIO Defendants, Sun Defendants, Alvogen and DRL Defendants (separate disclosure sent to each defendant group) filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 02/09/2023) (9) |
| Feb 3, 2023 | 123 | CLAIM Construction Chart by Novo Nordisk A/S, Novo Nordisk Inc.. (Attachments: # 1 Ex A - '383 Patent, # 2 Ex B - '154 Patent, # 3 Ex C - '953 Patent, # 4 Ex D - '462 Patent)(Murray, Travis) (Entered: 02/03/2023) (Main Document) (30) |
| Feb 3, 2023 | 124 | MOTION for Claim Construction re (75 in 1:22-cv-01040-CFC, 123 in 1:22-cv-00294-CFC, 98 in 1:22-md-03038-CFC) Claim Construction Chart - filed by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 02/03/2023) (7) |
| Feb 3, 2023 | 125 | MOTION for Claim Construction re (75 in 1:22-cv-01040-CFC, 123 in 1:22-cv-00294-CFC, 98 in 1:22-md-03038-CFC) Claim Construction Chart - filed by Mylan Pharmaceuticals Inc.. (Stamoulis, Stamatios) (Entered: 02/03/2023) (5) |
| Feb 3, 2023 | 123 | CLAIM Construction Chart by Novo Nordisk A/S, Novo Nordisk Inc.. (Attachments: # 1 Ex A - '383 Patent, # 2 Ex B - '154 Patent, # 3 Ex C - '953 Patent, # 4 Ex D - '462 Patent)(Murray, Travis) (Entered: 02/03/2023) (Ex A - '383 Patent) (15) |
| Feb 3, 2023 | 123 | CLAIM Construction Chart by Novo Nordisk A/S, Novo Nordisk Inc.. (Attachments: # 1 Ex A - '383 Patent, # 2 Ex B - '154 Patent, # 3 Ex C - '953 Patent, # 4 Ex D - '462 Patent)(Murray, Travis) (Entered: 02/03/2023) (Ex B - '154 Patent) (24) |
| Feb 3, 2023 | 123 | CLAIM Construction Chart by Novo Nordisk A/S, Novo Nordisk Inc.. (Attachments: # 1 Ex A - '383 Patent, # 2 Ex B - '154 Patent, # 3 Ex C - '953 Patent, # 4 Ex D - '462 Patent)(Murray, Travis) (Entered: 02/03/2023) (Ex C - '953 Patent) (16) |
| Feb 3, 2023 | 123 | CLAIM Construction Chart by Novo Nordisk A/S, Novo Nordisk Inc.. (Attachments: # 1 Ex A - '383 Patent, # 2 Ex B - '154 Patent, # 3 Ex C - '953 Patent, # 4 Ex D - '462 Patent)(Murray, Travis) (Entered: 02/03/2023) (Ex D - '462 Patent) (26) |
| Feb 2, 2023 | 122 | SO ORDERED, re (73 in 1:22-cv-01040-CFC, 96 in 1:22-md-03038-CFC, 121 in 1:22-cv-00294-CFC) STIPULATION TO EXTEND TIME for Certain Claim Construction Deadlines to Various Dates, filed by Novo Nordisk A/S, Novo Nordisk Inc. Reset Deadlines for Claim Construction Briefing and Markman Hearing: Joint Claim Construction Chart due by 2/3/2023. Claim Construction Opening Brief due by 2/24/2023. Claim Construction Answering Brief due by 3/17/2023. Claim Construction Reply Brief due by 4/6/2023. Claim Construction Surreply Brief due by 4/26/2023. Signed by Judge Colm F. Connolly on 2/2/2023. Associated Cases: 1:22-md-03038-CFC, 1:22-cv-00294-CFC, 1:22-cv-01040-CFC(kmd) (Entered: 02/02/2023) (5) |
| Feb 1, 2023 | 121 | STIPULATION TO EXTEND TIME for Certain Claim Construction Deadlines to Various Dates - filed by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 02/01/2023) (5) |
| Jan 31, 2023 | 119 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Novo Nordisk Commercial Holdings, Inc., Other Affiliate Novo Nordisk A/S, Other Affiliate Novo Nordisk US Holdings Inc. for Novo Nordisk Inc.; Corporate Parent Novo Holdings A/S, Other Affiliate Novo Nordisk Foundation for Novo Nordisk A/S filed by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 01/31/2023) (7) |
| Jan 31, 2023 | 120 | REDACTED VERSION of (116 in 1:22-cv-00294-CFC, 90 in 1:22-md-03038-CFC) Stipulation of Dismissal, by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC. (Kraman, Pilar) (Entered: 01/31/2023) (4) |
| Jan 27, 2023 | 117 | [SEALED] SO ORDERED, re (116 in 1:22-cv-00294-CFC, 90 in 1:22-md-03038-CFC) Stipulation of Dismissal as to Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc., and Zydus Lifesciences Limited regarding the '383, '239, '154, '611, '953, '155, '063, and '363 Patents, filed by Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc., Zydus Lifesciences Limited. Signed by Judge Colm F. Connolly on 1/27/2023.This order has been emailed to local counsel. Associated Cases: 1:22-cv-00294-CFC, 1:22-md-03038-CFC(kmd) (Entered: 01/27/2023) (0) |
| Jan 27, 2023 | 118 | NOTICE OF SERVICE of Plaintiffs' Notice to Sun of Subpoena for Production of Documents (confidential as to Sun Pharmaceutical Industries Ltd. And Sun Pharmaceutical Industries, Inc.) filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 01/27/2023) (8) |
| Jan 26, 2023 | 116 | [SEALED] STIPULATION of Dismissal as to Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc., and Zydus Lifesciences Limited regarding the '383, '239, '154, '611, '953, '155, '063, and '363 Patents by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC. (Kraman, Pilar) (Entered: 01/26/2023) (0) |
| Jan 25, 2023 | 115 | NOTICE OF SERVICE of Plaintiffs' Proposed Claim Constructions - filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 01/25/2023) (12) |
| Jan 24, 2023 | 114 | NOTICE OF SERVICE of Defendants Proposed Constructions and Intrinsic Evidence (with Exhibit A) filed by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Ltd..(Gattuso, Dominick) (Entered: 01/24/2023) (2) |
| Jan 23, 2023 | 109 | NOTICE OF SERVICE of (1) Defendants Rio Biopharmaceuticals Inc. and EMS S/A's response to Plaintiffs' Third Set of Collective Interrogatories (No. 14); and (2) Defendants Rio Biopharmaceuticals Inc. and EMS S/A's response to Plaintiffs' Third Set of Requests for Production (Nos. 93-98) filed by EMS S/A, Rio Biopharmaceuticals, Inc..(Dorsney, Kenneth) (Entered: 01/23/2023) (2) |
| Jan 23, 2023 | 110 | NOTICE OF SERVICE of 1) Defendants Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc., and Zydus Lifesciences Limited's Objections and Responses to Plaintiffs' Third Set of Collective Interrogatories to Defendants (No. 14); and 2) Defendants Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc., and Zydus Lifesciences Limited's Objections and Responses to Plaintiffs' Third Set of Requests for the Production of Documents and Things (Nos. 74-91) filed by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC.(Kraman, Pilar) (Entered: 01/23/2023) (2) |
| Jan 23, 2023 | 111 | NOTICE OF SERVICE of (i) DRL's Objections and Responses to Plaintiffs' Third Set of Collective Interrogatories to Defendants (No. 14); and, (ii) DRL's Responses and Objections to Plaintiffs' Second Set of Requests for the Production of Documents and Things (Nos. 95-100) filed by Dr. Reddy's Laboratories Ltd., Dr. Reddy's Laboratories Inc..(Gattuso, Dominick) (Entered: 01/23/2023) (2) |
| Jan 23, 2023 | 112 | NOTICE OF SERVICE of (1) Sun's Responses and Objections to Plaintiffs' Third Set of Collective Interrogatories (No. 14) and (2) Sun's Responses and Objections to Plaintiffs' Third Set of Requests for the Production of Documents and Things (Nos. 77-82) filed by Sun Pharmaceutical Industries Ltd., Sun Pharmaceuticals Industries Inc., Sun Pharmaceutical Industries Inc..(Metzler, Sara) (Entered: 01/23/2023) (2) |
| Jan 23, 2023 | 113 | NOTICE OF SERVICE of 1. Alvogen's Responses and Objections to Plaintiffs' Third Set of Requests for the Production of Documents and Things (Nos. 89-94) 2. Alvogen's Responses and Objections to Plaintiffs' Third Set of Collective Interrogatories (No. 14) filed by Alvogen, Inc..(Keller, Karen) (Entered: 01/23/2023) (2) |
| Jan 19, 2023 | 108 | NOTICE OF SERVICE of Plaintiffs' Identification of Inventors Employed by Plaintiffs and/or Represented by Counsel for Plaintiffs - filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 01/19/2023) (11) |
| Jan 13, 2023 | 107 | NOTICE OF SERVICE of Defendants' List of Proposed Terms for Construction filed by Dr. Reddy's Laboratories Ltd., Dr. Reddy's Laboratories Inc..(Gattuso, Dominick) (Entered: 01/13/2023) (2) |
| Jan 12, 2023 | 106 | NOTICE OF SERVICE of Plaintiffs' Preliminary Identification of Claim Terms Requiring Construction Pursuant to Paragraph 19 of the Scheduling Order (C.A. No. 22-294-CFC at D.I. 22; C.A. No. 22-1040-CFC at D.I. 53) - filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 01/12/2023) (11) |
| Jan 4, 2023 | 104 | STIPULATION and [Proposed] Order to Extend Certain Claim Construction Deadlines - by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 01/04/2023) (5) |
| Jan 4, 2023 | 105 | SO ORDERED, re (77 in 1:22-md-03038-CFC, 64 in 1:22-cv-01040-CFC, 104 in 1:22-cv-00294-CFC) Stipulation to Extend Certain Claim Construction Deadlines, filed by Novo Nordisk A/S, Novo Nordisk Inc. Signed by Judge Colm F. Connolly on 1/4/2023. Associated Cases: 1:22-cv-01040-CFC, 1:22-cv-00294-CFC, 1:22-md-03038-CFC(kmd) (Entered: 01/04/2023) (5) |
| Dec 22, 2022 | 102 | NOTICE OF SERVICE of Plaintiffs' Third Set of Collective Interrogatories to Defendants (No. 14) filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 12/22/2022) (11) |
| Dec 22, 2022 | 103 | NOTICE OF SERVICE of Plaintiffs' Third Set of Requests for the Production of Documents and Things (Individual Requests Served on Each Defendant Group) filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 12/22/2022) (9) |
| Dec 21, 2022 | 101 | NOTICE OF SERVICE of Novo Nordisk's Initial Responses to Defendants' Initial Invalidity Contentions Regarding U.S. Patent Nos. 8,129,343; 8,536,122; 8,114,833; 8,920,383; 9,775,953; 9,457,154; and 10,335,462 filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 12/21/2022) (11) |
| Dec 16, 2022 | 96 | NOTICE OF SERVICE of Defendants Rio Biopharmaceuticals Inc. and EMS S/A's responses to Plaintiff's Second Set of Collective Interrogatories (No. 13) filed by EMS S/A, Rio Biopharmaceuticals, Inc..(Dorsney, Kenneth) (Entered: 12/16/2022) (2) |
| Dec 16, 2022 | 97 | NOTICE OF SERVICE of Suns Responses and Objections to Plaintiffs Second Set of Collective Interrogatories (No. 13) filed by Sun Pharmaceutical Industries Ltd., Sun Pharmaceuticals Industries Inc., Sun Pharmaceutical Industries Inc..(Metzler, Sara) (Entered: 12/16/2022) (2) |
| Dec 16, 2022 | 98 | NOTICE OF SERVICE of Alvogen's Responses and Objections to Plaintiffs' Second Set of Collective Interrogatories to Defendants (No. 13) filed by Alvogen, Inc..(Keller, Karen) (Entered: 12/16/2022) (2) |
| Dec 16, 2022 | 99 | NOTICE OF SERVICE of Defendants Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc., and Zydus Lifesciences Limited's Objections and Responses to Plaintiffs Second Set of Collective Interrogatories to Defendants (No. 13) filed by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC.(Kraman, Pilar) (Entered: 12/16/2022) (2) |
| Dec 16, 2022 | 100 | NOTICE OF SERVICE of Plaintiffs' Initial Infringement Contentions (Individual Sets Served on Each Defendant Group) filed by Novo Nordisk A/S, Novo Nordisk Inc..(Egan, Brian) (Entered: 12/16/2022) (11) |
| Dec 15, 2022 | 95 | NOTICE OF SERVICE of DRL's Objections and Responses to Plaintiffs' Second Set of Collective Interrogatories to Defendants (No. 13) filed by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Ltd..(Gattuso, Dominick) (Entered: 12/15/2022) (2) |
| Dec 8, 2022 | 94 | NOTICE of Appearance by Alexis Stombaugh on behalf of Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC (Stombaugh, Alexis) (Entered: 12/08/2022) (3) |
| Dec 1, 2022 | 93 | NOTICE OF SERVICE of Plaintiffs' First Supplemental Disclosure of Asserted Patents and Claims as to Zydus Defendants - filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 12/01/2022) (3) |
| Nov 22, 2022 | 92 | NOTICE OF SERVICE of (1) Plaintiffs' Response to Defendants' First Set of Interrogatories (Nos. 1-4); and (2) Plaintiffs' Response to Defendants' First Set of Requests for Production (Nos. 1-23) filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 11/22/2022) (11) |
| Nov 21, 2022 | 91 | REDACTED VERSION of (87 in 1:22-cv-00294-CFC, 57 in 1:22-md-03038-CFC) Stipulation of Dismissal by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 11/21/2022) (4) |
| Nov 18, 2022 | 90 | NOTICE OF SERVICE of Defendants' Identification of Prior Art to Supplement Defendants' Initial Invalidity Contentions filed by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Ltd..(Gattuso, Dominick) (Entered: 11/18/2022) (2) |
| Nov 16, 2022 | 89 | NOTICE OF SERVICE of Plaintiffs' Second Set of Collective Interrogatories to Defendants (No. 13) filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 11/16/2022) (11) |
| Nov 15, 2022 | 88 | [SEALED] SO ORDERED, re (87 in 1:22-cv-00294-CFC, 57 in 1:22-md-03038-CFC) Stipulation of Dismissal as to Alvogen, Inc. Regarding the '239, '611, '155, '063, and '363 Patents (Joint), filed by Novo Nordisk A/S, Novo Nordisk Inc. Signed by Judge Colm F. Connolly on 11/15/2022.This order has been emailed to local counsel. Associated Cases: 1:22-md-03038-CFC, 1:22-cv-00294-CFC(kmd) Modified on 11/16/2022 (kmd). (Entered: 11/15/2022) (0) |
| Nov 14, 2022 | 87 | [SEALED] STIPULATION of Dismissal as to Alvogen, Inc. Regarding the '239, '611, '155, '063, and '363 Patents (Joint) by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 11/14/2022) (0) |
| Nov 8, 2022 | 85 | NOTICE OF SERVICE of (1) Plaintiffs' First Amended Disclosures to Defendants Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc., and Zydus Lifesciences Limited Pursuant to Rule 26(a)(1) of the Federal Rules of Civil Procedure and (2) Plaintiffs' First Amended Disclosures to Defendants Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc., and Zydus Lifesciences Limited Under Paragraph 3 of the District of Delaware Default Standard - filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 11/08/2022) (4) |
| Nov 8, 2022 | 86 | NOTICE OF SERVICE of (1) Plaintiffs' First Amended Disclosures Under Paragraph 3 of the District of Delaware Default Standard to the Sun Defendants and (2) Plaintiffs' First Amended Disclosures Pursuant to Rule 26(a)(1) of the Federal Rules of Civil Procedure to the Sun Defendants - filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 11/08/2022) (5) |
| Nov 3, 2022 | 84 | NOTICE OF SERVICE of Defendants Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc., and Zydus Lifesciences Limited's Objections and Responses to Plaintiffs' Second Set of Requests for the Production of Documents and Things (Nos. 11-73) filed by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC.(Kraman, Pilar) (Entered: 11/03/2022) (2) |
| Oct 27, 2022 | 80 | NOTICE OF SERVICE of DEFENDANTS RIO BIOPHARMACEUTICALS INC. AND EMS S/AS OBJECTIONS AND RESPONSES TO PLAINTIFFS SECOND SET OF REQUESTS FOR PRODUCTION OF DOCUMENTS (NOS. 11-92) filed by EMS S/A, Rio Biopharmaceuticals, Inc..(Hitch, Cortlan) (Entered: 10/27/2022) (2) |
| Oct 27, 2022 | 81 | NOTICE OF SERVICE of Suns Responses and Objections to Plaintiffs Second Set of Requests for the Production of Documents and Things (Nos. 11-76) filed by Sun Pharmaceutical Industries Ltd., Sun Pharmaceuticals Industries Inc., Sun Pharmaceutical Industries Inc..(Farnan, Kelly) (Entered: 10/27/2022) (2) |
| Oct 27, 2022 | 82 | NOTICE OF SERVICE of DRL's Responses and Objections to Plaintiffs' Second Set of Requests for the Production of Documents and Things (Nos. 11-94) filed by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Ltd..(Gattuso, Dominick) (Entered: 10/27/2022) (2) |
| Oct 27, 2022 | 83 | NOTICE OF SERVICE of Defendant's Responses and Objections to Plaintiffs' Second Set of Requests for the Production of Documents and Things (Nos. 11 - 88) filed by Alvogen, Inc..(Hoeschen, Nathan) (Entered: 10/27/2022) (2) |
| Oct 20, 2022 | 72 | [SEALED] SO ORDERED, re (70 in 1:22-cv-00294-CFC, 34 in 1:22-md-03038-CFC) Stipulation of Dismissal as to Rio Biopharmaceuticals Inc. and EMS S/A Regarding the '239 and '611 Patents, filed by Novo Nordisk A/S, Novo Nordisk Inc. Signed by Judge Colm F. Connolly on 10/20/2022.This order has been emailed to local counsel. Associated Cases: 1:22-md-03038-CFC, 1:22-cv-00294-CFC(kmd) (Entered: 10/20/2022) (0) |
| Oct 20, 2022 | 73 | NOTICE OF SERVICE of Defendants Rio Biopharmaceuticals Inc. and EMS S/A's Noninfringement Contentions Regarding Claims 12-14 of the '154 Patent filed by EMS S/A, Rio Biopharmaceuticals, Inc..(Dorsney, Kenneth) (Entered: 10/20/2022) (2) |
| Oct 20, 2022 | 74 | NOTICE OF SERVICE of Defendants Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc., and Zydus Lifesciences Limited's Initial Noninfringement Contentions filed by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC.(Kraman, Pilar) (Entered: 10/20/2022) (2) |
| Oct 20, 2022 | 75 | NOTICE OF SERVICE of copy of DRL's Noninfringement Contentions [CONFIDENTIAL] filed by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Ltd..(Gattuso, Dominick) (Entered: 10/20/2022) (2) |
| Oct 20, 2022 | 76 | NOTICE OF SERVICE of Sun's Initial Non-Infringement Contentions filed by Sun Pharmaceutical Industries Ltd., Sun Pharmaceuticals Industries Inc., Sun Pharmaceutical Industries Inc..(Farnan, Kelly) (Entered: 10/20/2022) (2) |
| Oct 20, 2022 | 77 | NOTICE OF SERVICE of Alvogen, Inc.'s Preliminary Non-Infringement Contentions filed by Alvogen, Inc..(Hoeschen, Nathan) (Entered: 10/20/2022) (2) |
| Oct 20, 2022 | 78 | MOTION for Pro Hac Vice Appearance of Attorney Aaron Z. Savit - filed by Alvogen, Inc.. (Hoeschen, Nathan) (Entered: 10/20/2022) (4) |
| Oct 20, 2022 | 79 | NOTICE OF SERVICE of Initial Invalidity Contentions filed by Sun Pharmaceutical Industries Inc., Sun Pharmaceutical Industries Ltd..(Metzler, Sara) (Entered: 10/20/2022) (3) |
| Oct 19, 2022 | 70 | [SEALED] STIPULATION and [Proposed] Order of Dismissal as to Rio Biopharmaceuticals Inc. and EMS S/A Regarding the '239 and '611 Patents - by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 10/19/2022) (0) |
| Oct 19, 2022 | 71 | REDACTED VERSION of (70 in 1:22-cv-00294-CFC, 34 in 1:22-md-03038-CFC) Stipulation - by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 10/19/2022) (3) |
| Oct 14, 2022 | 69 | NOTICE of Withdrawal of Joshua S. Reisberg by Alvogen, Inc. (Keller, Karen) (Entered: 10/14/2022) (2) |
| Oct 13, 2022 | 68 | ANSWER to Amended Complaint, re: 63 Amended Complaint by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC.(Kraman, Pilar) (Entered: 10/13/2022) (27) |
| Oct 7, 2022 | 64 | NOTICE OF SERVICE of Suns Responses and Objections to Plaintiffs First Set of Collective Interrogatories to Defendants (Nos. 1-12) filed by Sun Pharmaceutical Industries Ltd., Sun Pharmaceuticals Industries Inc., Sun Pharmaceutical Industries Inc..(Farnan, Kelly) (Entered: 10/07/2022) (2) |
| Oct 7, 2022 | 65 | NOTICE OF SERVICE of DRL's Objections and Responses to Plaintiffs' First Set of Collective Interrogatories to Defendants (Nos. 1-12) filed by Dr. Reddy's Laboratories Inc..(Gattuso, Dominick) (Entered: 10/07/2022) (2) |
| Oct 7, 2022 | 66 | NOTICE OF SERVICE of Defendants Responses to Plaintiffs First Set of Collective Interrogatories (Nos. 1-12) filed by Alvogen, Inc..(Keller, Karen) (Entered: 10/07/2022) (2) |
| Oct 7, 2022 | 67 | NOTICE OF SERVICE of Defendants Rio Biopharmaceuticals Inc. and EMS S/A's responses to Plaintiff's First Set of Collective Interrogatories (Nos. 1-12) filed by EMS S/A, Rio Biopharmaceuticals, Inc..(Dorsney, Kenneth) (Entered: 10/07/2022) (2) |
| Sep 29, 2022 | 63 | Amended Complaint* (1) |
| Aug 5, 2022 | 48 | Answer to Amended Complaint (30) Docket Text: ANSWER to Amended Complaint, re: [40] Amended Complaint , COUNTERCLAIM against Novo Nordisk A/S, Novo Nordisk Inc. by Sun Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Inc..(Farnan, Kelly) |
| Aug 4, 2022 | 46 | Proposed Order (30) Docket Text: PROPOSED ORDER --- Protective Order by Novo Nordisk A/S, Novo Nordisk Inc.. (Egan, Brian) |
| Aug 4, 2022 | 47 | Stipulation (17) Docket Text: STIPULATION -- Stipulated Order Regarding the Discovery of Electronically Stored Information by Novo Nordisk A/S, Novo Nordisk Inc.. (Egan, Brian) |
| Jul 29, 2022 | 45 | SO ORDERED (4) Docket Text: SO ORDERED, re [44] STIPULATION TO EXTEND TIME to submit a proposed order for discovery of electronically-stored information and a proposed Protective Order to August 4, 2022, filed by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Ltd. Signed by Judge Colm F. Connolly on 7/29/2022. (kmd) |
| Jul 28, 2022 | 44 | Stipulation to EXTEND Time (4) Docket Text: STIPULATION TO EXTEND TIME to submit a proposed order for discovery of electronically-stored information and a proposed Protective Order to August 4, 2022 - filed by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Ltd.. (Gattuso, Dominick) |
| Jul 22, 2022 | 42 | SO ORDERED (6) Docket Text: SO ORDERED, re [41] STIPULATION TO EXTEND TIME to submit a proposed order for discovery of electronically-stored information ("ESI Order") and a proposed Protective Order to July 28, 2022, filed by Novo Nordisk A/S, Novo Nordisk Inc. Signed by Judge Colm F. Connolly on 7/22/2022. (kmd) |
| Jul 22, 2022 | 43 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,129,343 B2 ;8,920,383 B2 ;9,457,154 B2 ;9,775,953 B2 ;9,132,239 B2 ;10,335,462 B2 . (Egan, Brian) |
| Jul 21, 2022 | N/A | Patent Report Notice (0) Docket Text: PATENT REPORT NOTICE: Please note that if patents are being added to this case, the filing party should complete the Report to Commissioner of Patents & Trademarks, and enter it on the docket using the PATENT/TRADEMARK REPORT event in the OTHER DOCUMENT list. The patent report form can be found at www.ded.uscourts.gov under the Clerk's Office FORMS button. (nmf) |
| Jul 21, 2022 | 38 | Main Document (6) Docket Text: MOTION for Leave to File Amended Complaint Against Sun (Unopposed) - filed by Novo Nordisk A/S, Novo Nordisk Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibits A-F to First Amended Complaint, # (3) Exhibit 2)(Egan, Brian) |
| Jul 21, 2022 | 38 | Exhibit 1 (17) |
| Jul 21, 2022 | 38 | Exhibits A-F to First Amended Complaint (161) |
| Jul 21, 2022 | 38 | Exhibit 2 (19) |
| Jul 21, 2022 | 39 | SO ORDERED (2) Docket Text: SO ORDERED, re [38] MOTION for Leave to File Amended Complaint Against Sun (Unopposed), filed by Novo Nordisk A/S, Novo Nordisk Inc. Signed by Judge Colm F. Connolly on 7/21/2022. (kmd) |
| Jul 21, 2022 | 40 | Main Document (17) Docket Text: AMENDED COMPLAINT against Sun Pharmaceutical Industries Inc., Sun Pharmaceutical Industries Ltd.- filed by Novo Nordisk Inc., Novo Nordisk A/S. (Attachments: # (1) Exhibits A-F)(kmd) |
| Jul 21, 2022 | 40 | Exhibit A-F (161) |
| Jul 21, 2022 | 41 | Stipulation to EXTEND Time (6) Docket Text: STIPULATION TO EXTEND TIME to submit a proposed order for discovery of electronically-stored information ("ESI Order") and a proposed Protective Order to July 28, 2022 - filed by Novo Nordisk A/S, Novo Nordisk Inc.. (Egan, Brian) |
| Jul 21, 2022 | 40 | Amended Complaint* (1) |
| Jul 14, 2022 | 30 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (i) Dr. Reddy's Laboratories, Ltd. and Dr. Reddy's Laboratories, Inc.'s Initial Disclosures Pursuant 2 to Rule 26(a)(1); and, (ii) Dr. Reddy's Laboratories, Ltd. and Dr. Reddy's Laboratories, Inc.'s Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery filed by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Ltd..(Gattuso, Dominick) |
| Jul 14, 2022 | 31 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of 1) Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc., and Zydus Lifesciences Limited's Initial Disclosures Pursuant to Paragraph 3 of the Delaware Default Standard for Discovery, and 2) Defendants Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc., and Zydus Lifesciences Limited's Fed. R. Civ. P. 26(a)(1) Initial Disclosures filed by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC.(Kraman, Pilar) |
| Jul 14, 2022 | 32 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Sun Pharmaceutical Industries Limited and Sun Pharmaceutical Industries Inc.'s Initial and Paragraph 3 Disclosures filed by Sun Pharmaceutical Industries Inc., Sun Pharmaceutical Industries Ltd..(Farnan, Kelly) |
| Jul 14, 2022 | 33 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' Disclosures Pursuant to Rule 26(a)(1) of the Federal Rules of Civil Procedure; and (2) Plaintiffs' Disclosures Under Paragraph 3 of the District of Delaware Default Standard (Alvogen) filed by Novo Nordisk A/S, Novo Nordisk Inc..(Egan, Brian) |
| Jul 14, 2022 | 34 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' Disclosures Pursuant to Rule 26(a)(1) of the Federal Rules of Civil Procedure; and (2) Plaintiffs' Disclosures Under Paragraph 3 of the District of Delaware Default Standard (DRL Defendants) filed by Novo Nordisk A/S, Novo Nordisk Inc..(Egan, Brian) |
| Jul 14, 2022 | 35 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' Disclosures Pursuant to Rule 26(a)(1) of the Federal Rules of Civil Procedure; and (2) Plaintiffs' Disclosures Under Paragraph 3 of the District of Delaware Default Standard filed by Novo Nordisk A/S, Novo Nordisk Inc..(Egan, Brian) |
| Jul 14, 2022 | 36 | Notice of Service (5) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' Disclosures Pursuant to Rule 26(a)(1) of the Federal Rules of Civil Procedure; and (2) Plaintiffs' Disclosures Under Paragraph 3 of the District of Delaware Default Standard (Sun Defendants) filed by Novo Nordisk A/S, Novo Nordisk Inc..(Egan, Brian) |
| Jul 14, 2022 | 37 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' Disclosures Pursuant to Rule 26(a)(1) of the Federal Rules of Civil Procedure; and (2) Plaintiffs' Disclosures Under Paragraph 3 of the District of Delaware Default Standard (Zydus Defendants) filed by Novo Nordisk A/S, Novo Nordisk Inc..(Egan, Brian) |
| Jul 13, 2022 | 28 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Rio Biopharmaceuticals Inc. and EMS S/A 's 26(a)(1) Initial Disclosures and; (2) Rio Biopharmaceuticals Inc. and EMS S/A 's Paragraph 3 Disclosures filed by EMS S/A, Rio Biopharmaceuticals, Inc..(Dorsney, Kenneth) |
| Jul 13, 2022 | 29 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Alvogen, Inc.'s Rule 26(a)(1) Initial Disclosures (2) Alvogen, Inc.'s Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery filed by Alvogen, Inc..(Hoeschen, Nathan) |
| Jul 12, 2022 | 23 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' First Set of Requests for the Production of Documents and Things (Nos. 1-10) Directed to Defendant Alvogen, Inc. filed by Novo Nordisk A/S, Novo Nordisk Inc..(Egan, Brian) |
| Jul 12, 2022 | 24 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of Plaintiffs' First Set of Requests for the Production of Documents and Things (Nos. 1-10) Directed to Defendants Dr. Reddy's Laboratories, Ltd. and Dr. Reddy's Laboratories, Inc. filed by Novo Nordisk A/S, Novo Nordisk Inc..(Egan, Brian) |
| Jul 12, 2022 | 25 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' First Set of Requests for the Production of Documents and Things (Nos. 1-10) Directed to Defendants Rio Biopharmaceuticals Inc. and EMS S/A filed by Novo Nordisk A/S, Novo Nordisk Inc..(Egan, Brian) |
| Jul 12, 2022 | 26 | Notice of Service (5) Docket Text: NOTICE OF SERVICE of Plaintiffs' First Set of Requests for the Production of Documents and Things (Nos. 1-10) Directed to Defendants Sun Pharmaceuticals Ltd. and Sun Pharmaceutical Industries, Inc. filed by Novo Nordisk A/S, Novo Nordisk Inc..(Egan, Brian) |
| Jul 12, 2022 | 27 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of Plaintiffs' First Set of Requests for the Production of Documents and Things (Nos. 1-10) Directed to Defendants Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc. and Zydus Lifesciences Limited filed by Novo Nordisk A/S, Novo Nordisk Inc..(Egan, Brian) |
| Jun 30, 2022 | 22 | Scheduling Order (30) Docket Text: SCHEDULING & CONSOLIDATION ORDER: These cases are consolidated for all purposes and all future filings shall be made in Lead Case No. 22-294-CFC ONLY. Joinder of Parties due by 8/1/2023. Amended Pleadings due by 8/1/2023. Fact Discovery completed by 10/20/2023. Expert Discovery due by 5/24/2024. Joint Claim Construction Brief due by 5/1/2023. A Markman Hearing is set for 6/29/2023 at 09:00 AM in Courtroom 4B before Judge Colm F. Connolly. Proposed Pretrial Order due by 8/29/2024. A Final Pretrial Conference is set for 9/19/2024 at 03:00 PM in Courtroom 4B before Judge Colm F. Connolly. A Bench Trial is set for 9/30/2024 at 08:30 AM in Courtroom 4B before Judge Colm F. Connolly. Signed by Judge Colm F. Connolly on 6/29/2022. Associated Cases: 1:22-cv-00294-CFC, 1:22-cv-00296-CFC, 1:22-cv-00297-CFC, 1:22-cv-00298-CFC, 1:22-cv-00299-CFC(nmf) |
| Jun 29, 2022 | N/A | Scheduling Conference (0) Docket Text: Minute Entry for proceedings held before Judge Colm F. Connolly - Scheduling Conference held on 6/29/2022. (Court Reporter Bonnie Archer.) Associated Cases: 1:22-cv-00294-CFC, 1:22-cv-00296-CFC, 1:22-cv-00297-CFC, 1:22-cv-00298-CFC, 1:22-cv-00299-CFC(nmf) |
| Jun 28, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [21] MOTION for Pro Hac Vice Appearance of Attorney Stephen R. Auten, Attorney Philip Y. Kouyoumdjian and Attorney Jaimin H. Shah, filed by Rio Biopharmaceuticals, Inc., EMS S/A. Ordered by Judge Colm F. Connolly on 6/28/2022. (kmd) |
| Jun 28, 2022 | 21 | Motion for Leave to Appear Pro Hac Vice (5) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Stephen R. Auten, Attorney Philip Y. Kouyoumdjian and Attorney Jaimin H. Shah - filed by EMS S/A, Rio Biopharmaceuticals, Inc.. (Dorsney, Kenneth) |
| Jun 27, 2022 | 20 | Main Document (1) Docket Text: Letter to The Honorable Colm F. Connolly from Brian P. Egan regarding the Court's June 6, 2022 Order - re (19 in 1:22-cv-00294-CFC, 21 in 1:22-cv-00298-CFC, 19 in 1:22-cv-00296-CFC, 20 in 1:22-cv-00299-CFC, 25 in 1:22-cv-00297-CFC) Order Setting Scheduling Conference,. (Attachments: # (1) [Proposed] Scheduling Order)(Egan, Brian) |
| Jun 27, 2022 | 20 | [Proposed] Scheduling Order (38) |
| Jun 6, 2022 | 19 | Order Setting Scheduling Conference (3) Docket Text: Order Setting Telephonic Scheduling Conference: A Scheduling Conference is set for 6/29/2022 at 04:00 PM Telephonically before Judge Colm F. Connolly. If the parties have no disputes about the scheduling order, the Court will not require the parties to appear at a conference. Signed by Judge Colm F. Connolly on 6/6/2022. Associated Cases: 1:22-cv-00294-CFC, 1:22-cv-00296-CFC, 1:22-cv-00297-CFC, 1:22-cv-00298-CFC, 1:22-cv-00299-CFC(nmf) |
| Jun 3, 2022 | 18 | Letter (1) Docket Text: Letter to The Honorable Colm F. Connolly from Brian P. Egan regarding coordinated discovery and Markman proceedings - re (13 in 1:22-cv-00296-CFC, 13 in 1:22-cv-00296-CFC, 15 in 1:22-cv-00294-CFC, 15 in 1:22-cv-00294-CFC, 19 in 1:22-cv-00297-CFC, 19 in 1:22-cv-00297-CFC, 15 in 1:22-cv-00299-CFC, 15 in 1:22-cv-00299-CFC, 17 in 1:22-cv-00298-CFC, 17 in 1:22-cv-00298-CFC) Order,,, Set Deadlines,,. (Egan, Brian) |
| May 31, 2022 | 17 | Answer to Counterclaim (16) Docket Text: ANSWER to [11] Answer to Complaint, Counterclaim - by Novo Nordisk A/S, Novo Nordisk Inc..(Egan, Brian) |
| May 24, 2022 | 16 | Notice Requesting Removal of Co-Counsel (7) Docket Text: NOTICE requesting Clerk to remove Kara Czekai as co-counsel. Reason for request: No longer with firm. (Egan, Brian) |
| May 11, 2022 | 15 | Order (3) Docket Text: ORDER: IT IS ORDERED that, on or before June 13, 2022, counsel for plaintiffs shall inform the court as to whether the need for coordinated discovery and/or Markman proceedings is anticipated as to the above cases and, if so, when a joint scheduling conference might most efficiently be conducted. ORDER, Setting Deadlines: ( Notice of Compliance deadline set for 6/13/2022.) Signed by Judge Colm F. Connolly on 5/11/2022. Associated Cases: 1:22-cv-00294-CFC, 1:22-cv-00296-CFC, 1:22-cv-00297-CFC, 1:22-cv-00298-CFC, 1:22-cv-00299-CFC(nmf) |
| May 9, 2022 | 11 | Answer to Complaint (30) Docket Text: ANSWER to [1] Complaint, , COUNTERCLAIM against Novo Nordisk A/S, Novo Nordisk Inc. by EMS S/A, Rio Biopharmaceuticals, Inc..(Dorsney, Kenneth) |
| May 9, 2022 | 12 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Rio Biopharmaceuticals, Inc. for EMS S/A filed by EMS S/A, Rio Biopharmaceuticals, Inc.. (Dorsney, Kenneth) |
| May 9, 2022 | 13 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Rio Biopharmaceuticals Inc.'s production of core technical documents pursuant to Chief Judge Connolly's Standing Order on Hatch Waxman cases filed by EMS S/A, Rio Biopharmaceuticals, Inc..(Dorsney, Kenneth) |
| May 9, 2022 | 14 | Main Document (1) Docket Text: Letter to The Honorable Colm F. Connolly from Brian P. Egan regarding JPML filing. (Attachments: # (1) Attachment)(Egan, Brian) |
| May 9, 2022 | 14 | Attachment (1209) |
| May 6, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (15 in 1:22-cv-00298-CFC, 10 in 1:22-cv-00294-CFC, 13 in 1:22-cv-00297-CFC, 10 in 1:22-cv-00296-CFC, 9 in 1:22-cv-00299-CFC) MOTION for Pro Hac Vice Appearance of Attorney Jeffrey J. Oelke, Ryan P. Johnson, Robert E. Counihan, Laura T. Moran, Erica R. Sutter, Kara Czekai, and Olivia Wheeling, filed by Novo Nordisk A/S, Novo Nordisk Inc. Ordered by Judge Colm F. Connolly on 5/6/2022. Associated Cases: 1:22-cv-00294-CFC, 1:22-cv-00296-CFC, 1:22-cv-00297-CFC, 1:22-cv-00298-CFC, 1:22-cv-00299-CFC. (kmd) |
| May 6, 2022 | 10 | Motion for Leave to Appear Pro Hac Vice (12) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Jeffrey J. Oelke, Ryan P. Johnson, Robert E. Counihan, Laura T. Moran, Erica R. Sutter, Kara Czekai, and Olivia Wheeling - filed by Novo Nordisk A/S, Novo Nordisk Inc.. (Egan, Brian) |
| Mar 14, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [9] STIPULATION TO EXTEND TIME for Rio Biopharmaceuticals Inc. and EMS S/A to answer, move or otherwise respond to the Complaint to May 9, 2022, filed by Novo Nordisk A/S, Novo Nordisk Inc. Reset Answer Deadlines: Rio Biopharmaceuticals, Inc. answer due 5/9/2022. Ordered by Judge Colm F. Connolly on 3/14/2022. (kmd) |
| Mar 11, 2022 | 8 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by Novo Nordisk Inc., Novo Nordisk A/S: For EMS S/A waiver sent on 3/8/2022, answer due 5/9/2022. (Egan, Brian) |
| Mar 11, 2022 | 9 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for Rio Biopharmaceuticals Inc. and EMS S/A to answer, move or otherwise respond to the Complaint to May 9, 2022 - filed by Novo Nordisk A/S, Novo Nordisk Inc.. (Egan, Brian) |
| Mar 9, 2022 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. Associated Cases: 1:22-cv-00294-CFC through 1:22-cv-00299-CFC (rjb) |
| Mar 7, 2022 | 7 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Novo Nordisk Inc., Novo Nordisk A/S. Rio Biopharmaceuticals, Inc. served on 3/7/2022, answer due 3/28/2022. (Egan, Brian) |
| Mar 4, 2022 | 1 | Main Document (11) Docket Text: COMPLAINT filed against EMS S/A and Rio Biopharmaceuticals, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3817543.) - filed by Novo Nordisk Inc. and Novo Nordisk A/S. (Attachments: # (1) Exhibit A-E, # (2) Civil Cover Sheet)(mal) |
| Mar 4, 2022 | 1 | Exhibit A-E (146) |
| Mar 4, 2022 | 1 | Civil Cover Sheet (1) |
| Mar 4, 2022 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mal) |
| Mar 4, 2022 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 01/24/2022. Date of Expiration of Patent: see attached.Thirty Month Stay Deadline: 06/05/2025. (mal) |
| Mar 4, 2022 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,129,343 B2 ;9,132,239 B2 ;9,457,154 B2 ;9,687,611 B2 ;10,335,462 B2. (mal) |
| Mar 4, 2022 | 5 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Novo A/S for Novo Nordisk A/S; Corporate Parent Novo Nordisk US Holdings, Inc. for Novo Nordisk Inc. filed by Novo Nordisk A/S, Novo Nordisk Inc.. (mal) |
| Mar 4, 2022 | 6 | Main Document (2) Docket Text: Summons Issued as to EMS S/A on 3/4/2022; Rio Biopharmaceuticals, Inc. on 3/4/2022. (Attachments: # (1) Summons Issued EMS S/A)(mal) |
| Mar 4, 2022 | 6 | Summons Issued EMS S/A (2) |
| Mar 4, 2022 | 1 | Complaint* (1) |
